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ABSTRACT 
Research was undertaken to examine different in vitro characteristics of probiotic 
bacteria, including Lactobacillus acidophilus ATCC® 11975™, Bifidobacterium infantis ATCC 
15697D, Bifidobacterium catenulatum ATCC® 27675 and Bifidobacterium adolescentis ATCC® 
15703™ in order to identify suitable strain(s) for encapsulation. Under simulated gastric 
conditions (pH 2.0), L. acidophilus was the most acid-tolerant strain (D-value 10.2 ± 0.8 min), 
and was able to survive for 30 min; whereas, the other tested probiotics underwent a rapid 
(within the first 5 min at pH 2.0) 4-5 log cfu/mL loss in viability. All probiotics tested were able 
to survive 5 h exposure to 0.3% Oxgall bile at pH 5.8. The relative ranking of probiotic 
adherence to Caco-2 cells was determined to be: L. acidophilus >B. catenulatum >B. 
adolescentis >B. infantis, which correlated with 4.5  104, 3.1  103, 2.6  101, and 1.5  101 
cfu/mL associated with Caco-2 cell monolayers, respectively. The most hydrophobic probiotics 
included L. acidophilus (46.5 ± 6.1%) and B. catenulatum (65.5 ± 5.2%); their hydrophobicity 
were positively correlated with auto-aggregation ability. Addition of divalent cations, EDTA, 
and bile salts were found to affect hydrophobicity as well; for example, 0.5 mM MgCl2 resulted 
in a 20% increase in cell surface hydrophobicity of L. acidophilus from baseline levels; whereas, 
the addition of 0.1 and 0.5% bile salts decreased L. acidophilus hydrophobicity from control 
levels by 60 and 90%, respectively. Cell free culture supernatant of L. acidophilus effectively 
inhibited the growth of Escherichia coli O157:H7, and Clostridium sordelli. Bactericidal activity 
of L. acidophilus cell-free supernatant (the lethal factor was determined to be both heat and 
trypsin-resistant) against Escherichia coli O157:H7 and Clostridium sordelli ATCC 9714 over 
24 h resulted in reductions of 5.5 and 3.5 log cfu/mL, respectively. Further examination of 
probiotics revealed varying degrees of resistance to the antimicrobial agents ciprofloxacin (4 
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µg/mL), naladixic acid (32 µg/mL), kanamycin (64 µg/mL) and sulfisoxazone (256 µg/mL). 
Determination of carbon source utilization patterns indicated that B. catenulatum utilized a 
number of carbohydrates including -methyl-D-glucoside, D-xylose, D-cellobiose, and -D-
lactose; whereas, L. acidophilus, B. infantis, and B. adolescentis utilized D-xylose. L. 
acidophilus was ultimately selected for encapsulation in a 3 mm diameter pea protein-alginate 
matrix followed by in vitro challenge to simulated gastric conditions (pH 2.0). Encapsulation of 
L. acidophilus demonstrated a significant (P < 0.05) protective effect during the 2 h exposure to 
simulated acidic stomach conditions; within capsules, there was approximately 1 log cfu/mL loss 
in cell viability, whereas unprotected cells experienced >6 log/mL loss in cell viability over the 
same period.  
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1 General introduction 
Probiotics are microorganisms introduced orally in the gastrointestinal tract (GIT) that 
are able to contribute positively to the activity of intestinal microflora and therefore, to the health 
of its host. Most probiotic bacteria belong to the group of lactic acid bacteria (LAB) and among 
them lactobacilli and bifidobacteria reportedly play a significant role in maintaining the intestinal 
ecosystem and in stimulating the immune system of the host (Saarela et al., 2002).  Many in vitro 
properties, such as adhesion, resistance to pH, etc., are usually investigated to determine if a 
specific selected strain would be suitable as a probiotic (Collins et al., 1998). 
Co-aggregation is a process by which genetically-distinct bacteria adhere to one another 
via specific molecules. Cumulative evidence suggests that such adhesion influences the 
development of complex multispecies biofilms (Ricard et al., 2003). Bacterial aggregation 
between microorganisms of the same strain (auto-aggregation) or between genetically divergent 
strains (co-aggregation) is of considerable importance in several ecological niches, especially 
inH the human gut, where probiotics are to be active (Collado et al., 2007a). A relationship 
between auto-aggregation and adhesion ability has been reported for some bifidobacterial spp. 
(Del Re et al., 2000; Collado et al., 2007b). A correlation between adhesion ability and 
hydrophobicity, as measured by microbial adhesion to hydrocarbons, has also been observed in 
some lactobacilli (Del Re et al., 2000). Furthermore, it has been suggested (Collado et al., 2007b) 
that inhibitor- or bacteriocin-producing LAB, which co-aggregates with pathogens, may 
constitute an important host defence mechanism against infection. Co-aggregation with potential 
gut pathogens could therefore contribute to the probiotic properties ascribed to specific LAB. 
The determination of antimicrobial susceptibility of a bacterial strain is an important 
prerequisite for its approval as a probiotic (Moubareck et al., 2005). The resistance gene 
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reservoir hypothesis (Ammor et al., 2007) suggests that beneficial and commensal bacterial 
populations play a role in the transfer of antibiotic resistance to pathogenic and opportunistic 
bacteria. At present, there is great concern that commensal bacterial populations from food and 
the GIT of humans and animals, such as LAB and bifidobacteria, could act as a reservoir for 
antibiotic resistance genes. Resistance factors could ultimately be transferred to human 
pathogenic and opportunistic bacteria, thereby hampering the treatment of infections and general 
spread of antimicrobial resistance. LAB spp. have traditionally been used as starter cultures in 
the production of fermented feed and foodstuffs. Further, LAB and bifidobacteria are normal 
inhabitants of the GIT where they are known to exert health-promoting effects, and these 
selected strains are currently been used as probiotics. Antibiotic resistance genes carried by LAB 
and bifidobacteria could be transferred to human pathogenic bacteria either during food 
manufacture or during passage through the GIT (Ammor et al., 2007).  
The overall goal of this research is to screen four probiotic bacteria, including 
Lactobacillus acidophilus ATCC 11975, Bifidobacterium infantis ATCC 15697, B. catenulatum 
ATCC 27675 and B. adolescentis ATCC 15703, for characteristics that make them effective 
candidates for encapsulation.  
1.1 Hypotheses 
The following hypothesis will be tested during this research: 
a) Biochemical characterization of probiotic bacteria will identify candidates suitable for 
evaluation of probiotic encapsulation technology. 
b) Probiotic encapsulation using pea protein-alginate beads will enhance probiotic survival 
in simulated gastric juice. 
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1.2 Technical objectives 
The following objective will be investigated: 
a) To examine a panel of probiotic bacteria for their ability to survive and or grow in low 
pH environments, as well as in the presence of bile salts; 
b) To quantify the adherence of probiotic bacteria to intestinal epithelial surfaces, as well as 
their ability to co-aggregate with other enteric flora; 
c) To determine the antimicrobial potential of probiotic bacteria against a panel of selected 
enteric pathogens; 
d) To characterize probiotic bacteria using BIOLOG sole carbon source utilization, and 
antimicrobial profiling, to assist in strain-specific discrimination of the probiotic 
organism from other bacteria that colonize the gut environment; and 
e) To utilize protein-alginate capsules to determine the effect of encapsulation of probiotic 
bacteria on survival in a model acidic (pH 2.0) gastric system. 
2 Literature review  
Foods are no longer considered by consumers only in terms of taste and immediate 
nutritional needs, but also in terms of their ability to provide specific health benefits beyond their 
basic nutritional value. Currently, the largest segment of the functional food market is provided 
by the foods targeted towards improving the balance and activity of the intestinal microflora 
(Saarela et al., 2002). Consumption of foods containing live bacteria is the oldest and still most 
widely used way to increase the numbers of advantageous bacteria in the intestinal tract. Such 
bacteria are called ‘Probiotics’ and have been predominantly selected from the genera 
Lactobacillus and Bifidobacterium, both of which have been extensively studied and established 
as valuable native inhabitants of the GIT (Fuller, 1989; Salminen et al., 1998, Capela et al., 
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2006). Various microorganisms, particularly species of Lactobacillus and Streptococcus, have 
traditionally been used in fermented dairy products to promote human health as well as food 
functionality and flavor. 
2.1 Historical perspective of probiotics 
Escherich described the microbiota of the infant GIT and suggested benefits of their 
colonization in digestion. Around the same time, Doderlein postulated the beneficial association 
of vaginal bacteria in inhibiting the growth of pathogenic bacteria by producing lactic acid 
(Goktepe et al., 2006). Studies by Moro in 1900 and by Beijerinck in 1901 reported the 
beneficial association of LAB with human host (Goktepe et al., 2006). The longevity of 
Caucasians was related to the high intake of fermented milk products (Metschnikoff, 1907), as 
elucidated in his bestselling book The Prolongation of Life. LAB belong to a group of Gram-
positive, non-sporulating, non-respiring cocci or rods, which produce lactic acid as a major 
metabolic end product during the fermentation of carbohydrates (Salminen et al., 1998). 
Although phylogenetically different, bifidobacteria are another group of lactic acid producing 
bacteria which are commonly accepted as LAB. Bifidobacteria were found to be typically 
associated with the feces of breast-fed infants and a lower incidence of intestinal upset was 
observed for breast-fed infants, when compared with formula-fed infants (Goktepe et al., 2006).  
2.1.1 Definition of probiotics 
The word probiotic is derived from the Greek meaning “for life”. Probiotics were first 
defined by Kollath in 1953 to denote all organic and inorganic food complexes in contrast to 
harmful antibiotics. Lilly and Stillwell (1965) defined probiotics as “microorganisms promoting 
the growth of other microorganisms”. Although numerous definitions have been proposed since 
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then, most have failed to be completely satisfactory because they lack statements such as 
“stabilization of the gut flora” (Goktepe et al., 2006). Havenaar and Veld (1992) have defined 
probiotics as “mono- or mixed cultures of live microorganisms which, when applied to animal or 
human, beneficially affect the host by improving the properties of the indigenous microflora”. 
When these probiotic bacteria are present in yogurt and other fermented foods, they may 
beneficially alter the normal gut flora (Metchnikoff, 1907). Probiotics have also been defined by 
the European Union (EU) Expert Group on Functional Foods in Europe (FUFOSE) to be “viable 
preparations in foods or dietary supplements to improve the health of humans and animals” 
(FUFOSE working group, 1999). More recently, probiotics have been referred to as “live 
microorganisms which when administered in adequate amounts confer a health benefit on the 
host” (FAO/WHO, 2001).  
2.2 The gastrointestinal ecosystem 
The GIT of the human body is a complex ecosystem with a diverse and concentrated 
microbial population that mediates numerous interactions with the chemical environment, such 
as digestion, adhesion and colonization in the GIT. The mucosal surface area increases by: 
circular folding which contributes to about a 3-fold increase, through the production of villi, for a 
7- to 10-fold increase, and by the formation of intestinal microvilli, which results in a 15- to 40-
fold increase (Holzapfel et al., 1998). Varying numbers of bacteria are found throughout the GIT, 
ranging from 101-103 cfu/mL or g in the stomach contents; 107 cfu/mL in the jejunum, up to 109 
cfu/g in the terminal ileum and approximately 5 × 1011 cfu/g in the distal colon contents 
(Goktepe et al., 2006).  
The bacteria detected in feces reflect the bacteria present in the distal colon, thus studies 
of the human GIT microflora usually involve analysis of fecal samples (Moore et al., 1978). 
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Traditional culture methods have been used to analyze and characterise microbial communities 
in a natural ecosystem to obtain a complete diversity picture. In contrast to the microaerophillic 
lactobacilli, the study of anaerobic bifidobacteria and eubacteria was made possible by the 
development of anaerobic techniques in the early 1970s (Goktepe et al., 2006). However, 
cultivation techniques have major limitations, as many microbes in different ecosystems cannot 
be cultivated by standard culture methods (Ward et al., 1990). Classical culture-independent 
techniques include direct microscopic analysis and monitoring specific enzymes or metabolites, 
and have provided valuable insight into the real numbers of microflora in faecal samples. 
Microscopic analysis of faecal samples by Langendijk et al. (1995) revealed approximately 1011 
to 1012 organisms per g of wet feces. It is noteworthy that these techniques are very limited in 
their ability to give any in-depth characterisation of specific organisms present or community 
diversity. Fluorescence microscopy, confocal laser scanning microscopy and flow cytometry 
have been used to detect viable populations through the use of fluorescent probes (Lipski et al., 
2001). If epifluorescence microscopy and/or confocal laser scanning microscopy are applied, the 
method is usually referred to as fluorescence in situ hybridization (FISH). FISH has been used to 
study the composition of GIT microbial system (Tannock et al., 2000). Various studies reported 
that the microscopic technique itself is not perfect and may significantly under-report the true 
numbers (Ward et al., 1990).  
 Various short chain fatty acids (SCFA), such as acetate, propionate and butyrate, are end 
products of anaerobic bacterial fermentation. Thus, measurement of these acids in feces can be 
correlated with specific bacterial metabolism in the intestine (Rowland, 1989). For example, 
Lactobacillus casei GG fed to children with an intestinal infection significantly increased the 
total SCFA concentration (Siigur et al., 1996). Increases or decreases in specific enzymes for 
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example, β-glucuronidase and β-galactosidase, in feces can also point to the metabolic activities 
of certain groups of bacteria. Reduction in β-glucuronidase levels was reported in humans during 
ingestion of L. casei GG (Ling et al. 1994). Also, a significant correlation has been observed 
between the levels of faecal β-galactosidase and numbers of bifidobacteria (Favier et al., 1997). 
While many faecal enzymes, such as azoreductase and nitroreductase are mainly produced by the 
species Bacteroides, Eubacterium and Clostridium, more studies are needed to accurately 
correlate specific faecal enzymes with specific groups of bacteria (Rowland, 1989).  
 Cell viability can also be inferred from enzymatic activities such as esterase conversion 
of carboxyfluorescein diacetate (cFDA). The reduction of tetrazolium salts, or dyes such as 
propidium iodide, TOTO-1, SYTO 9, carboxyfluorescein and oxonol, have been used as viability 
indicators (Goktepe et al., 2006). Bunthof et al. (2001) have combined culture plating technique 
with dyes, and reported that cFDA labels the culturable subpopulation; whereas, TOTO-1 lables 
the non-culturable population. Determination of percentages of guanine+cytosine (G+C) content 
is one of the few methods depicting the total bacterial community of the GIT without any 
previous knowledge of component bacteria or their DNA sequences (Apajalahti et al., 1998). 
This approach has been applied by Apajalahti et al. (2003) to determine the total bifidobacteria 
community in human feces.  
 DNA-based methods for the detection of probiotic microorganisms are mainly based on 
restriction enzyme analysis or PCR (Polymerase Chain Reaction), or both. Various methods 
including amplified fragment length polymorphism (AFLP), pulsed field gel electrophoresis 
(PFGE), Random amplification of polymorphic DNA (RAPD) including multiplex PCR, 
arbitrary primed PCR (AP-PCR) and tiplicate arbitrary-primed PCR (TAP-PCR) has been used 
for identification and tracking of individual probiotic strains (Gardiner et al., 2002). AFLP is a 
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combination of PCR and restriction enzyme analysis, where genomic DNA is digested with two 
different types of restriction endonucleases. Strain specific identification using AFLP method has 
been used to differentiate Lactobacillus plantarum, Lactobacillus pentosus and Lactobacillus 
paraplantarum (Torriani et al., 2001). PFGE has been used for typing Lactobacillus casei, 
bifidobacteria and Lactobacillus rhamnosus (Goktepe et al., 2006). 
 RAPD is a PCR-based method in which a pattern of amplicons is produced through the 
simultaneous amplification of many chromosomal sequences mediated by annealing of short 
oligonucleotide primers. RAPD PCR analysis has been reported to be capable of differentiating 
between L. acidophilus group strains (Pleiss et al., 1995). This technique has also been found to 
be useful for monitoring introduced and indigenous lactobacilli in the intestinal tract (Gardiner et 
al., 2002). RAPD PCR analysis of yeast isolates from feta cheese provided reliable identification 
at species level and good discrimination at the strain level (Psomas et al., 2001). In AP-PCR, 
reactions are performed by using specific primer targeting a highly conserved region within the 
16S rRNA gene. TAP-PCR is a variation of AP-PCR, where three different annealing 
temperatures are used in triplicate reactions, and has been used by Cusick and O’Sullivan (2000) 
to type isolates from major genera of LAB and bifidobacteria. The primers used in the 
amplification reaction in Rep-PCR and ERIC-PCR techniques targets the species specific Rep 
(Repetitive extragenic palindromic) elements and ERIC (enterobacterial repetitive intergenic 
consensus) sequences, which are conserved regions dispersed on the genomic DNA of 
microorganisms. The profiles obtained due to the amplification of inter-Rep and inter-ERIC 
distances are species and sometimes strain specific (Goktepe et al., 2006).  
  Other culture-independent techniques which can mediate the identification of individual 
bacterial species or strains include denaturing gradient gel electrophoresis (DGGE), which has 
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been used to detect lactobacillus and other species in the human GIT (Walter et al., 2001). 
Accurate typing of unknown isolates is now achieved through sequence analysis of 16S 
ribosomal RNA (rRNA) or the corresponding rDNA amplicons following PCR. Matsuki et al. 
(2002) has investigated the microbial population of six healthy human volunteers by applying 
16S rRNA-gene-targeted group-specific-oligonucleotide primers for the Bacteroides fragilis 
group, Bifidobacterium, the Clostridium coccoides group, and Prevotella, and identified 74% of 
the predominant bacteria in the feces. Another method called amplified ribosomal DNA 
restriction analysis (ARDRA) has been developed on the basis of 16s rRNA gene amplification 
followed by restriction analysis, and was used by Ventura et al. (2000) to identify different 
species of Lactobacillus isolated from human feces and vagina. 
  Andersson et al. (2008) has developed a method based on 454-pyrosequencing for 
monitoring of microbial communities in throat, stomach and fecal samples. Pyrosequencing is a 
method of DNA sequencing based on the sequencing by synthesis, which involves taking a 
single strand of the DNA to be sequenced and then synthesizing its complementary strand 
enzymatically. A highly variable region of the 16S rRNA gene is amplified using primers that 
target adjacent conserved regions, followed by direct sequencing of individual PCR products. 
The cpn60 gene (encoding the universally conserved 60 kDa chaperonin), has been established 
as a useful target for molecular phylogenetics, characterization of complex microbial 
communities and to differentiate between closely related bacterial isolates by hybridization or 
sequence analysis (Dumonceaux et al. 2006). An approximately 555-bp segment of the gene 
corresponding to nucleotides 274–828 of the Escherichia coli cpn60 sequence (the cpn60 
universal target, or cpn60 UT) can be amplified from virtually any genome using universal, 
degenerate PCR primers. The cpn60 based identification of fecal microflora of cats has revealed 
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diverse populations dominated by Actinobacteria (particularly bifidobacteria) and Firmicutes 
(particularly lactobacilli) (Desai et al. 2009).  
2.2.1 Gastrointestinal strains of human origin  
In spite of increased research on gut microbial ecology, only a small number of 
approximately 400 species of different genera have been cultivated and studied with regard to 
their physiology, metabolic interactions, and taxonomy (Goktepe et al., 2006). Table 2.2.1 
presents the LAB found likely to be associated with the human host (Goktepe et al., 2006). The 
large intestine is densely populated by Bacteriodes and the Gram-positive, anaerobic genera 
Eubacterium and Bifidobacterium. Lactobacilli are the predominant species in the vagina and are 
also normally present in the oral cavity (103-104 cfu/g), the ileum (103-107 cfu/g), and colon        
(104-108 cfu/g), where they play an important role in maintenance of a stable gut mucosa 
(Lidbeck et al., 1993). Long and Swenson (1977) showed that bifidobacteria and lactobacilli are 
the dominant bacterial species found to be present in the feces of breast-fed infants. There is a 
lack of research evidence that has demonstrated a single dominant species in the human GIT. 
However, L. acidophilus (commonly referred as simply “acidophilus”) has been recovered in 
relatively high numbers from the GIT (Molin et al., 1993). Strains of acidophilus have been 
isolated from the intestinal tract of humans as well as animals such as rodents and birds. 
 LABs are gram-positive, non-spore forming, catalase-negative organisms that are devoid 
of cytochromes and anaerobic but aerotolerant. They are fastidious, acid-tolerant, and strictly 
fermentative (either homo- or hetero); lactic acid is the major end product of sugar fermentation 
(Axelsson, 1998). However, some species can form catalase or cytochromes on media containing 
hematin or related compounds and some lactobacilli can also produce non-heme catalase, called 
pseudocatalase, which cause confusion for LAB identification (Holzapfel et al., 2001). 
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Table 2.2.1 LAB typically associated with the human host (Goktepe et al., 2006) 
 
Lactobacilli Other LAB 
Intestinal Bacteria  
Lactobacillus acidophilus group 
Bifidobacterium 
adolescentis 
L. acidophilus senso strictu B. angulatum 
L. animalis B. bifidum 
L. brevis B. breve 
L. buchneri B. cantenulatum 
L.crispatus B. dentium 
L. curvatus B. infantis 
L. delrueckii B. longum 
L. fermentum B. pseudocantenulatum 
L. gasseri Enterococcus fecalis 
L. johnsonii E. faecium 
L. paracasei Leuc. Mesenteroides 
L. plantarum Pedicoccus pentosaceus 
L. reuteri Weissella confusa 
L. rhamnosus  
L. ruminis  
L. sakei  
  
Vaginal Bacteria  
Lactobacillus acidophilus Bifidobacterium bifidum 
L. fermentum B. longum 
L. casei B. infantis 
L. rhamnosus B. breve 
L. cellobiosus B. catenulatum 
L. plantarum B. dentium 
L. brevis  
L. delbrueckii  
L. salivarious  
L. jensenii  
L. vaginalis  
L. gasseri  
L. crispatus   
 
2.3 Probiotic bacteria  
Strains of LAB, such as Lactobacillus, Bifidobacterium, Eubacterium and Streptococcus, 
have traditionally been used in the manufacture of fermented dairy products and are generally 
regarded as safe (GRAS) (O’Sullivan et al., 1992). In addition, these bacteria are desirable 
members of the intestinal microflora (Berg, 1998). Table 2.3.1 shows a list of microorganisms 
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including both LAB and non-lactics which are generally considered as probiotics. Lack of 
pathogenicity, tolerance to gastrointestinal conditions (acid and bile), ability to adhere to the 
gastrointestinal mucosa and competitive exclusion of pathogens (Collins et al., 1998; Ouwehand 
et al., 2002) are some of the general criteria that have been used for the selection of probiotics.  
L. casei strain “Shirota” has been reported to have the longest history of safe use as a probiotic in 
food with proven health benefits (Goktepe et al., 2006). Lactobacillus acidophilus and 
Bifidobacterium bifidum were used to make mildly acidified yogurts called “bio-yogurts” in 
Germany during late 1960s (Goktepe et al., 2006). Viable probiotic strains with beneficial 
functional properties are supplied in the market as fermented food products, mainly “yogurt”-
type, or in lyophilized form, both as food supplements and as pharmaceutical preparations. For 
many years, pharmaceutical preparations containing live microorganisms in capsules, also 
known as “biotherapeutics”, were used for the restoration of the GIT population, e.g., after or 
during antibiotic treatment (Goktepe et al., 2006).  
 The prevalence of lactobacillus and bifidobacterial spp. in the intestinal tract of humans is 
not known accurately. Lactobacillus crispatus, L. gasseri, L. salivarius, and L. reuteri have been 
reported as the major species of the Lactobacillus microflora (Mitsuoka et al., 1990). Whereas, 
Lactobacillus johnsonii, Lactobacillus ruminis, Lactobacillus casei, and Lactobacillus brevis 
have been detected occasionally. Bifidobacterium longum has been found predomonently in adult 
human GIT, while Bifidobacterium bifidum was detected occasionally. In contrast, 
Bifidobacterium infantis and Bifidobacterium breve were detected predominantly in infant feces, 
while B. longum and B. bifidum detected occasionally (Biavati et al., 1984).  
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Table 2.3.1 Microorganisms considered as probiotics (Adapted from Holzapfel et al., 2001) 
 
Lactobacillus spp. Bifidobacterium spp. Other LAB "Non-lactics" a 
L. acidophilus B. adolescentis Enterococcus  faecalis a Bacillus cereus 
L. amylovorus B. animalis Ent. faecium ("toyoi") a,c 
L. casei B. bifidum Sporolactobacillus Escherichia colia 
L. crispatus B. breve inulinusc Propionibacterium 
L. delbrueckii subsp. B. infantis  freudenreichii a,c 
bulgaricus a B. lactis b  Saccharomyces 
L. gallinarum c B. longum  cerevisiae 
L. gasseri   ("boulardii") a 
L. johnsonii    
L. paracasei    
L. plantarum    
L. reuteri    
L. rhamnosus       
a Mainly in pharmaceutical preparations; b Synonym of  B. animalis; c Mainly for animals. 
   
 On the basis of their morphologic and phenotypic features, the LAB are subdivided 
(Table 2.3.2) into the genera Betabacterium, Thermobacterium, Streptobacterium, Streptococcus, 
Betacoccus, Tetracoccus, and Microbacterium (Holzapfel et al., 2001). Enterococcus, 
Lactococcus, and Vagococcus have been separated from the original genus, Streptococcus 
(Holzapfel et al., 2001). The genus Streptococcus represents mainly pathogenic bacteria, except 
Streptococcus thermophilus; whereas, some strains of Enterococcus spp. may be involved in 
opportunistic infections, and some are considered to play role in food fermentations, and are also 
found as commensals in the GIT. Lactococcus spp. are generally considered to be non-
pathogenic and safe.  
 Probiotic Bifidobacterium spp. are generally strict anaerobes. Fermentation of the sugars 
and sugar alcohols like L-arabinose, D-xylose, D-mannose, salicin, D-mannitol, D-sorbitol, and 
D-melezitose serve as key characteristics to identify the most important species of bifidobacteria 
(Klein et al., 1998). 
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Table 2.3.2 Key to differentiating lactic acid bacteria and a comparison with current taxonomic 
classification (Adapted from Holzapfel et al., 2001) 
 
Genus Shape Catalase Nitrite reduction Fermentation Current genera 
Betabacterium Rod − − Hetero- Lactobacillus 
     Weissella 
Thermobacterium Rod − − Homo- Lactobacillus 
Streptobacterium Rod − − Homo- and Hetero Lactobacillus 
     Carnobacterium 
Streptococcus Coccus − − Homo- Streptococcus 
     Enterococcus 
     Lactococcus 
     Vagococcus 
Betacoccus Coccus − − Hetero- Leuconostoc 
     Oenococcus 
     Weissella 
     Brochothrix 
Microbacterium Rod + + Homo- Pediococcus 
Tetracoccus Coccus + + Homo- Tetragenoccus 
 
Analysis of the cell wall peptidoglycan composition was also found suitable for the 
identification of some species like Bifidobacterium longum, Bifidobacterium infantis, and 
Bifidobacterium suis (Bonaparte, 1997). Practically all organisms used in probiotic foods or food 
supplements are representatives of the genera Lactobacillus, Enterococcus, or Bifidobacterium. 
The genus Bifidobacterium shares some phenotypic features with typical LAB and is considered 
to form part of the LAB. Phylogenetically-distinct, bifidobacteria exhibit a relatively high G + C 
content of 55–67 mol% in the DNA and form part of the Actinomycetes branch. The “true” LAB 
form part of Clostridium branch, which is characterized by a G + C content of <55 mol% in the 
DNA. Genes encoding rRNA, comprising conserved and variable domains, are typically chosen 
for phylogenetic work as they are present in all microorganisms. Analysis of the 16s rRNA gene 
is considered to be the most powerful and accurate technique for determining the degree of 
phylogenetic relation of microorganisms.  
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The phylogenetic relation of the different genera of “true” LAB is shown in Figure 2.3.1 
and is based on the comparison of 16S rRNA sequences. Carnobacterium, Enterococcus, 
Vagococcus, Aerococcus, Tetragenococcus, and Lactosphaera are more closely related to each 
other than to any other LAB. Lactobacilli are phylogenetically diverse, whereas Lactococcus and 
Streptococcus are closely related. Lactobacillus and Pediococcus are mixed, phylogenetically, as 
shown by the 16S rRNA sequencing data with 5 species of a Pediococcus clustering with 32 
homo- and hetero-fermentative Lactobacillus spp. in the so-called Casei and Pediococcus group 
(Collins et al., 1991). In 16S rRNA sequence data of pediococci and lactobacilli, the taxa 
generated do not correspond with the phylogenetic branching. Therefore, certain species of LAB 
may have to be reclassified.  
Performing a preliminary in vitro assessment is a prerequisite to assess the properties of 
probiotic bacterial strains (FAO/WHO, 2002). Various papers (Dunne et al., 2001; Morelli, 
2007) have suggested that a probiotic bacterial strain should be assessed according to the 
following (or a very similar) criteria: human origin, nonpathogenic behavior, resistance to 
technologic processes (i.e., viability and activity in delivery vehicles), resistance to gastric 
acidity and bile toxicity, adhesion to gut epithelial tissue, ability to persist within the 
gastrointestinal tract, production of antimicrobial substances, ability to modulate immune 
responses, and ability to influence metabolic activities (e.g., cholesterol assimilation, lactase 
activity, and vitamin production). It has also been suggested that the demonstration of probiotic 
activity of a certain strain involve well-designed, double-blind, placebo-controlled human studies 
(Dunne et al., 2001). 
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Figure 2.3.1 Consensus tree, based on comparative sequence analysis of 16S rRNA, showing 
major phylogenetic groups of lactic acid bacteria with low mol% guanine plus cytosine in the 
DNA and the non-related gram-positive genera Bifidobacterium and Propionibacterium 
(Adapted from Holzapfel et al., 2001) 
 
Health benefits associated with the ingestion of probiotic bacteria includes: reduction in 
colon irritation, constipation, traveler’s diarrhea, inhibition of the adhesion of pathogenic genera 
including Escherichia, Clostridium, Salmonella and Campylobacter to the intestinal lumen, 
synthesis of B vitamins, lowering of blood ammonia levels, cholesterol absorption and inhibition 
of tumor formation (Ziemer and Gibson, 1998). Some reported health benefits of probiotic 
bacteria are listed in Table 2.3.3. 
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Table 2.3.3 Some Probiotic bacterial and yeast strains and their reported health effect (Adapted 
from Dunne et al., 2001) 
 
Strain Reported effects 
Lactobacillus 
acidophilus LC1 
Immune enhancing, vaccine adjuvant, adherence to human intestinal cells, 
balancing of intestinal microflora 
  
L. acidophilus 
NCFO1748 
Lowering of fecal enzymes, prevention of radiotherapy-related diarrhea, 
treatment of constipation 
  
L. rhamnosus GG Prevention of antibiotic-associated, rotavirus, acute and Clostridium 
difficile diarrhea, antagonistic against carcinogenic bacteria 
  
L. casei Shirota Balancing of intestinal bacteria, lowering of fecal enzymes, inhibition of 
bladder cancer 
  
L. gasseri Fecal enzyme reduction, survival in the intestinal tract 
  
Bifidobacterium 
bifidum 
Treatment of rotavirus diarrhea, balancing of intestinal microflora 
  
Saccharomyces 
boulardii 
Prevention of traveler's diarrhea, prevention and treatment of Cl. difficile 
diarrhea 
 
2.3.1 Acid resistance of probiotics 
 More than two liters of gastric juice with a pH as low as 1.5 is secreted from cells lining 
the stomach each day, providing a normally-effective, high-acid barrier against entrance of 
viable bacteria into the GIT. The effect of gastric pH on bacterial viability and in preventing 
bacterial colonization of the small intestine is well-studied (Simon and Gorbach, 1987; Heatley 
and Sobala, 1993). Consequently, any probiotic organism that is to survive transit through the 
stomach must have a high acid tolerance. In typical acid tolerance tests, the viability of candidate 
probiotic organisms is determined by exposing them to low pH in a buffer solution or medium 
for a period of time, during which the number of surviving bacteria remaining is determined.  
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 Minekus et al. (1995) has developed a dynamic computer-controlled model, which 
reflects the in vivo conditions of the stomach and small intestine. This model permits an accurate 
simulation of the factors influencing the survival of probiotic microorganisms, such as pH, bile 
concentration and transit through the different parts of the GIT. Studies by Dunne et al. (2001) 
suggested that lactobacilli isolated from human ileal samples could successfully transit the 
human stomach conditions and function effectively. In these studies, bifidobacteria were found 
to be less resistant to stomach conditions like low pH etc. than lactobacilli. Studies by Conway et 
al. (1987) showed that yogurt-producing species of lactobacilli were more sensitive to gastric 
juice while enteric species were more resistant. The best-performing among the two                   
L. acidophilus strains (strain ADH) used in the study were reclassified as Lactobacillus gasseri, 
which is a homofermentative lactobacilli (Morelli, 2000). Lactobacillus rhamnosus GG was 
unable to survive at pH 1.0, but remained viable at pH 3.0 and higher (Goldin et al., 1992). In 
vitro studies (Hood and Zottola, 1988; Charteris et al., 1998a) showed that enteric lactobacilli 
had a lower pH tolerance limit of 2.0 for several min. Eight meat starter cultures including 
Lactobacillus and Pediococcus strains were exposed to low pH (pH 1.0 to 5.0) conditions of 
stomach for 1 h. The number of surviving bacteria was decreased from the inoculated level of  
7.4-7.6 log cfu/mL to < 4 log cfu/mL at pH 1.0 and pH 2.0, whereas pH 4.0 and 5.0 did not affect 
the viability (Erkkila and Petaja, 2000). Only 51 out of 312 pre-selected LAB strains, including 
Lactobacillus, Pediococcus, Enterococcus, isolated from Iberian dry fermented sausages, human 
and pig feces were able to survive after 1.5 h of exposure at pH 2.5, where the number of final 
surviving bacteria ranges between 5.4 to 8.9 log cfu/g (Ruiz-Moyano et al., 2008). The bile 
resistant isolates of Bifidobacterium strains displayed considerably higher survival at 90 min of 
exposure at pH 2.0, with a concentration of final surviving bacteria ~ 6.5 log cfu/mL, than their 
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corresponding strains of origin (Noriega et al., 2004). Survival of Bifidobacterium animalis 
strains BLC-1, Bb-12, and Bo, Lactobacillus acidophilus strains LAC-1 and Ki, Lactobacillus 
paracasei subsp. paracasei strain LCS-1 and Lactobacillus brevis strain LMG 6906 inoculated 
into whey cheese was assessed by Madureira et al. (2005). Except L. paracasei subsp. paracasei 
LCS-1 and B. animalis Bb-12, all bacteria were resistant to the action of artificial gastric juice 
(pH 2.5–3.0) and maintained their initial viable cell numbers (~ 8 log cfu/mL) after both 60 and 
120 min of exposure.  
 In order to evaluate the survival of lactobacilli in the low pH conditions of the human 
stomach, five Lactobacillus strains were compared in simulated gastric juice (SGJ, pH 2.0) for 
90 min (Corcoran et al., 2005). Lactobacillus rhamnosus GG had the highest survival rate and 
maintained their initial viable cell numbers (~ 9 log cfu/mL), while the poorest survivor was      
L. paracasei NFBC 338, whose concentration declined to undetectable levels after only 30 min 
of exposure. These studies also showed that glucose (19.4 mM) was responsible for the enhanced 
survival of L. rhamnosus GG in simulated gastric juice. The level of surviving bacteria was 
reduced by approximately 5.6 log cfu/mL upon removal of glucose (Corcoran et al., 2005). 
Furthermore, five Lactobacillus strains were examined for their acid tolerance (pH 2.5). 
Lactobacillus acidophilus NCFM was found to be the least acid tolerant, with a final surviving 
population of 6.0 × 104 cfu/mL, whereas the population of L. acidophilus 30SC and ATCC 
43121 remained relatively constant (~ 6 log cfu/mL) (Oh et al., 2000).  
 Probiotics have been incorporated into a range of dairy products, including yoghurts, 
soft-, semi-hard and hard cheeses, ice cream, milk powders and frozen dairy desserts. However, 
there are still several problems with respect to the low viability of probiotic bacteria in GIT and 
food environments. Probiotics of intestinal origin are difficult to propagate and high survival is 
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important for both economic reasons and health effects. Consequently, there is a demand for new 
technologies such as encapsulation to enhance probiotic viability.  
2.3.2 Bile resistance of probiotics 
 Bile is an aqueous solution made up of bile acids, cholesterol, phospholipids, and the 
pigment biliverdin, which gives the bile its yellow-green color. About 500-700 mL/day of bile 
acids are synthesized in the liver from cholesterol and are secreted from the gall bladder into the 
duodenum, after food intake by an individual (Hofmann and Roda, 1984). Bile plays an essential 
role in lipid digestion; it emulsifys and solubilizes lipids and functions as biological detergent. 
Prior to secretion into the duodenum, bile acids are conjugated either with glycine 
(glycoconjugated) or taurine (tauroconjugated) (Begley et al., 2006). In the colon conjugated bile 
undergoes various chemical changes including deconjugation, dehydroxylation, 
dehydrogenation, and deglucuronidation, almost solely by microbial activity (Begley et al., 
2006). The antimicrobial nature of bile is mainly because of its detergent property, which 
dissolves bacterial membranes. Bile salt hydrolases (BSHs) are generally intracellular, oxygen-
insensitive enzymes that catalyze the hydrolysis of bile salts. Hydrolysis of bile salts is mediated 
by various genera of the intestinal microflora, including Clostridium (Gopal et al., 1996), 
Bacteroides (Kawamoto et al., 1989), Lactobacillus (Lundeen and Savage, 1990; Christiaens et 
al., 1992), Bifidobacterium (Grill et al., 2000a) and Enterococcus (Franz et al., 2001). A number 
of BSHs have been identified and characterized in probiotic bacteria, and the ability of probiotic 
strains has often been included among the criteria for probiotic strain selection (Begley et al., 
2006). Bile tolerance of probiotic bacteria can be investigated by incubating them for 24 hrs in a 
milk-yeast medium containing different concentrations of bile extracts and monitoring cell 
viability and pH before and after incubation (Goktepe et al., 2006). This assay was used by 
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several authors to assess the bile resistance of potential or already commercialized probiotic 
lactobacilli. All these studies reported a growth delay of lactobacilli in the presence of oxgall that 
was strain- and not species-dependent. It has been hypothesized that deconjugation of bile salts is 
a detoxification mechanism and BSH enzymes play a role in bile tolerance of probiotic 
organisms in the GIT (Savage, 1992). Both conjugated and deconjugated bile acids have been 
determined to inhibit the growth of Klebsiella spp., Enterococcus spp. and Escherichia coli 
strains in vitro. However, deconjugated forms of bile acids were found to be more inhibitory 
against Gram-positive than Gram-negative bacteria (Stewart et al., 1986). Studies by Smet et al. 
(1995) suggested that deconjugation of bile acids decreases their solubility and thus diminishes 
the detergent’s activity and makes it less toxic to bacteria in the intestine. It was assumed that the 
conjugated form of the bile salts exhibits toxicity by causing intracellular acidification through 
the same mechanism as organic acid. In contrast, Tannock et al. (1989) stated that deconjugated 
bile salts are more inhibitory than conjugated bile salts to anaerobes including lactobacilli. 
Similarly, deconjugated bile was reported to be involved in growth inhibition of Bifidobacterium 
spp. including B. breve, B. longum, and B. coryneforme, where the viable counts were reduced 
by approximately 6, 7 and 2 log cfu/mL respectively, after 2 h incubation in the presence of 1 
mM deconjugated bile (Grill et al., 2000b). Another hypothesis states that certain Clostridium 
spp. utilize the amino acid taurine as an electron acceptor and have demonstrated improved 
growth rates in the presence of taurine and taurine-conjugated bile salts (Moser and Savage, 
2001). However, taurine or taurine conjugates did not affect the growth of Lactobacillus spp. 
tested (Tannock et al. 1989). Cholic acid was found to accumulate in lactobacillus cells by means 
of a transmembrane proton gradient (Kurdi et al., 2000). Whereas studies by Boever et al. (2000) 
reported that cholic acid was highly deleterious for the viability of lactobacilli. It has also been 
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suggested that the BSH enzymes are detergent shock proteins (Adamowicz et al., 1991) that 
protects the lactobacilli from its toxic effects and may have a competitive advantage over the 
non-BSH producing bacteria. However, studies of Moser and Savage (2001) reported that 
deconjugation and resistance are unrelated activities. Lastly, studies done by Gopal et al. (1996) 
showed no relationship between the ability of 6 strains of L. acidophilus and 8 strains of 
Bifidobacterium spp. to grow in bile (0.3% oxgall) and their ability to hydrolyze bile salts 
(glycocholic acid or taurocholic acid).  
A link between bile salt hydrolysis and bile tolerance has been provided by the studies 
conducted on wild-type and bsh mutant pairs of Lactobacillus plantarum, Lactobacillus 
amylovorus and Listeria monocytogenes. Results showed that mutant cells were significantly 
more sensitive to bile and bile salts and displayed decreased growth rates in the presence of bile 
salts (Begly et al., 2006).  
2.3.3 Probiotic adhesion to human intestinal cells   
 It is generally agreed that LAB must adhere to intestinal mucus or epithelial cells in order 
to persist in the gut. The ability of LAB to adhere to mucosal surfaces prevents their rapid 
removal by gut contraction and subsequent peristaltic flow of digesta, and could also confer a 
competitive advantage. A large body of research has been conducted to screen probiotic bacteria 
for their ability to attach to intestinal cells (Goktepe et al., 2006). In vitro experimentation shows 
that some strains of Lactobacillus adhere to intestinal tissue cultured cells in a species-dependent 
way (Fuller, 1975). However, other studies concluded that the capacity to adhere to the surface is 
undoubtedly insufficient by itself to ensure that the microorganisms can colonize the epithelial 
habitat (Savage, 1984). Cultured human intestinal cell line models, which express various 
specific characteristics of cell phenotypes of intestinal epithelium, have been used to study 
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probiotic adhesion. Clones of the HT-29 and Caco-2 cell lines such as absorptive Caco-2BB2, 
Caco-2/TC7 cells and HT29-19A cells, and the mucin-secreting HT29-C1.16E cells have been 
established (Servin, 2004). These cell lines have been shown to undergo morphological and 
functional differentiation in vitro, a characteristic feature of mature enterocytes of the small 
intestine. Moreover, these cell line models form junctional complexes, and so constitute a 
monolayer that mimics the intestinal epithelial barrier (Cereijido et al., 1998). Chauviere et al. 
(1992a) observed that bacterial adhesiveness is a strain-specific property. He found that among 
twenty-five strains of lactobacilli, seven adhered to enterocyte-like Caco-2 cells, whereas only 
three of them, including L. acidophilus, possessed calcium-independent adhesiveness.  
 The L. acidophilus LA 1 strain exhibited a high calcium independent adhesion onto 
human enterocyte like Caco-2 cells (Figure 2.3.2) and also bound strongly to the mucus secreted 
by the homogeneous cultured human goblet cell line HT29-MTX (Bernet et al., 1994). Heat-
killed L. acidophilus LB was also found to adhere to Caco-2 and HT-29 cell line models 
(Coconnier et al., 1993). Several Bifidobacterium spp., including B. adolescentis, B. angulatum, 
B. bifidum, B. breve, B. catenulatum, B. infantis, B. longum, B. pseudocatenulatum, B. breve 4, 
B. infantis 1 and B. lactis DR10 also adhered to Caco-2 and HT29-MTX cells (Gopal et al., 
2001). Furthermore, the in vitro adhesion index system (Table 2.3.4) has proven to be extremely 
sensitive to factors such as pH, the presence of calcium ions, the number of lactobacilli, the 
presence of culture supernatant, and the growth phase in which the bacteria were harvested 
(Tuomola and Salminen, 1998; Blum and Reniero, 2000). 
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Figure 2.3.2 Examination by scanning electron microscopy of adherence of Lactobacillus 
acidophilus strain 1 onto the differentiated human intestinal epithelial cells Caco-2. (A) Low 
magnification of Caco-2 monolayer covered by L. acidophilus bacteria; (B) High magnification 
of L. acidophilus whole cells (Bernet et al., 1994) 
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Table 2.3.4 Lactobacilli with an adhesion index of at least one bacterium per Caco-2 cell 
(Adapted from Morelli, 2000) 
 
Strain Source Adhesion index 
L. acidophilus BG2FO4 Human 2.3 
L. johnsonii LA1 Human 1.55 
L. acidophilus LB Human 2.1 
L. rhamnosus GG Human  1.25 
L. acidophilus C7 Chicken  1.5 
L. helveticus CNRZ239 Dairy 1.4 
L. helveticus CNRZ 240 Dairy 2.1 
L. delbrukii subsp. lactis CNRZ 239 Dairy 1.9 
L. delbrukii subsp. lactis ATCC 7830 Unknown 2.3 
L. delbrukii subsp. lactis LY Yogurt 1.5 
 
2.3.4 Antagonistic activities of probiotics against pathogens 
 LAB has a number of properties which make them highly suitable for probiotic 
therapeutics that are of pharmaceutical interest. Several mechanisms have been ascribed to 
probiotic action such as competitive exclusion, production of antimicrobial compounds, 
modulation of immune response, alternation of intestinal bacterial metabolic activity, alteration 
of microecology of the human intestine, and inhibition of bacterial translocation.  
2.3.4.1 Competitive exclusion (CE) 
 CE can be defined as the principle that if two species try to occupy the same ecological 
niche, a superior species will eventually emerge to replace the inferior one (Vine et al., 2004). 
Various studies reported that adhesive probiotic bacteria can prevent the attachment of pathogens 
and remove them from the intestinal tract (Benno and Mitsuoka, 1992; Vine et al., 2004). CE of 
uropathogenic Enterococcus faecalis by Lactobacillus isolates were reported by Velraeds et al. 
(1996) in their in vivo studies done in a rat model of urinary infection. Heat-killed L. acidophilis 
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strain LB that adheres to the Caco-2 cell lines, was shown to inhibit the adhesion of 
diarrheagenic E. coli in a concentration-dependent manner (Chauviere et al., 1992b). The 
mechanism of CE in this study was explained to involve steric hindrance. Two Bifidobacterium 
strains including B. bifidum M6 and B. bifidum A1 were assessed for their ability to inhibit the 
adhesion and the displacement of enteropathogens including Clostridium difficile ATCC 9689, 
Enterobacter sakazakii ATCC 29544, Salmonella enterica serovar typhimurium ATCC 29631, 
Escherichia coli NCTC 8603 and Listeria monocytogenes ATCC 15313 (Gueimonde et al., 
2007). The levels of displacement varied between 15 and 70% depending on the strains used. 
Higher affinity of Bifidobacterium strains for the receptors present in the mucus was explained as 
a mechanism of pathogen displacement in this study.  
2.3.4.2 Co-aggregation of probiotics 
 Aggregation between microorganisms of the same strain (auto-aggregation), or between 
different species and strains (co-aggregation) for example with pathogens, as well as their ability 
to displace pathogens is an important property of probiotic organisms and may have greater 
advantage over non-co-aggregating organisms which are easily removed from GIT environment. 
The interaction of probiotic organisms with the natural gut flora is key to the potential success of 
the organism in terms of colonization and long-term persistence. Co-aggregation of probiotic 
bacterial strains has been suggested to enable them to form a physical-chemical barrier that 
prevents colonization by pathogenic bacteria (Collado et al., 2007b). Lactobacilli have been 
found to co-aggregate with some uropathogenic bacteria and inhibit their growth (Redondo-
Lopez et al. 1990). Co-aggregation of Lactobacillus acidophilus, Lactobacillus gasseri, and 
Lactobacillus jensenii with pathogens like Candida albicans, E. coli, and Gardnerella vaginalis 
was observed by Boris et al. (1998). Furthermore, self-aggregation or clumping may 
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substantially increase the colonization potential of lactobacilli in environments with short 
residence times such as GIT. It has been hypothesized that combinations of probiotic bacterial 
strains may improve the health benefits compared to the strains alone (Collado et al., 2007b). 
2.3.4.3 Probiotics modulating the immune response  
 The GIT is a complex ecosystem which contains up to 1 × 1014 cfu of bacterial cells of 
various phenotypes lining the epithelial wall and expressing complex metabolic activities 
(Zboril, 2002). The mechanism(s) of the immune response of the intestinal microbiota have been 
explained (Nicaise et al., 1999) by examining the regulation of interleukin-1 (IL-1), IL-6, tumor 
necrosis factor-α (TNF-α) and IL-12 production in macrophages from germ-free and from    
flora-associated mice, and germ-free mice colonized with E. coli and found that IL-12 
production in the spleen was enhanced by intestinal flora. Interleukins are implicated in 
determining the relative levels of T-helper 1 (Th1) and T-helper 2 (Th2) responses, and play an 
important role in defending the host against intracellular microorganisms. Immune regulation 
involves homeostasis between Th1 and Th2 activity, with Th1 cells driving the type-1 pathway 
(cellular immunity) and Th2 cells driving the type-2 pathway (humoral immunity). The most 
important function of the resident intestinal microbiota is to act as a microbial barrier against 
pathogens by influencing humoral and cellular mucosal immune responses during the neonatal 
phase of life, and thereafter to maintain a physiologically-normal steady-state condition of 
inflammation throughout life (Cebra, 1999). In innate mucosal immunity, the host defense 
mechanisms are triggered as a result of specific recognition of pathogen-associated molecular 
patterns (PAMPs). Whereas, all endogenous bacterial species of the microbiota share microbe-
associated molecular patterns (MAMPs). Epithelial and monocytic cells can sense the 
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environment of the GIT by means of pattern-recognition receptors (PRR) (Didierlaurent et al., 
2002). 
2.3.4.4 Production of antimicrobial compounds by probiotics 
 Several antimicrobial substances have been found to be produced by LAB that have 
considerable advantages in competition with pathogens and other harmful bacteria (Soomro et 
al., 2002). These substances include fatty acids, organic acids, hydrogen peroxide, and diacetyl, 
acetoin and the best studied small, heat-stable inhibitory peptides called ‘bacteriocins’ (Simova 
et al., 2009). The term bacteriocin was first introduced by Jacobs and coworkers in 1953, and 
defined as protein antibiotics of relative high molecular weight mainly working against the same, 
or closely related, species by adsorption to receptors on the target cells (Salminen and Wright, 
1998a). Bacteriocins produced by LAB were divided into three classes: 1) lantibiotics; 2) small 
hydrophobic heat-stable peptides, and 3) large heat-labile proteins (Drider et al., 2006; see table 
2.3.5).  
 The most common Lactobacillus spp. known to produce bacteriocins are Lactobacillus 
sakei and Lactobacillus curvatus. Lactobacillus sakei has been shown to possess antimicrobial 
activity against Listeria monocytogenes due to the production of the bacteriocins sakacin A, M, 
P, 674, K, and T (Schillinger and Lucke, 1989). The only purified bacteriocin approved for use 
in products for human consumption is nisin, which is produced by Lactococcus lactis subsp. 
lactis strains (Jack et al., 1995). Escherichia coli participates in antibacterial defense by 
producing colicins that function by forming pores in the cell membrane rendering the cells 
permeable to nuclease activity (Riley and Wertz, 2002). 
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Table 2.3.5 Classification of LAB bacteriocins (Adapted from Drider et al., 2006) 
 
Class Characteristics Subcategory Examples 
I Lantibiotics (containing 
lanthionine and β-lanthionine) 
Type A (elongated molecules; 
molecular mass, < 4 kDa) 
 
Nisin A 
Nisin Z 
Subtilin 
Epidermin 
    
  
Type B (globular molecules; 
molecular mass, 1.8 to 2.1 kDa) 
Mersacidin 
Actagardin 
Mutacin II 
 
    
II Non-modified heat-stable 
bacteriocins containing 
peptides 
Subclass IIa (antilisterial 
pediocin-like bacteriocins) 
Sakacin P, G, 
A etc. 
 
with molecular masses of <10 
kDa   
  
Subclass IIb (two-peptide 
bacteriocins) 
Plantaricin EF 
Plantaricin JK 
    
  
Subclass IIc (other peptide 
bacteriocins) 
Lactococcin 
972 
    
III Protein bacteriocins with 
molecular masses of >30kDa  
Helveticin J 
Millericin B 
       
   
 The antimicrobial action of bacteriocins involves increased permeability of the 
cytoplasmic membrane of the target cells for a broad range of monovalent cations, such as Na+, 
K+, Li+, Cs+, Rb+ and choline, which leads to the destruction of proton motive force by 
dissipation of the transmembrane pH gradient and eventually to cell death (Oppegard et al., 
2007; Simova et al., 2009). Bactericidal activity (Figure 2.3.3) of a bacteriocin-like substance 
produced by vaginal Lactobacillus salivarius subsp. salivarius CRL 1328 with activity against 
Enterococcus faecalis, E. faecium, and Neisseria gonorrhoeae has also been reported (Ocana et 
al., 1999).  
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  Corr et al. (2007) demonstrated the in vivo antimicrobial effects of L. salivarius 
UCC118 against L. monocytogenes primarily depended on their capacity to produce the 
bacteriocin, Abp118. Lactobacillus spp. strain GG, isolated from the feces of a normal person, 
was reported to produce a bacteriocin with inhibitory activity in the pH range between 3 and 5 
against a wide variety of bacterial species including Gram-positive and Gram-negative 
organisms (Silva et al., 1987).  
 
Figure 2.3.3 Electron photomicrographs of the effect of L. salivarius subsp. salivarius CRL 1328 
bacteriocin-like substance on E. faecalis. The Enterococcus control cell (A), vesiculization of 
protoplasm (B), vesiculization of protoplasm and a damaged cell wall (C), pore formation in the 
cell wall (D), a disintegrated cell with loss of the protoplasmic material through a cell wall pore 
(E), and a disintegrated cell (F) (Ocana et al., 1999) 
 
 LAB produces lactic acid as the major metabolic end-product of sugar 
fermentation. Besides exerting its activity through lowering the pH and through its undissociated 
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form, lactic acid is also known to function as a permeabilizer of the Gram-negative bacterial 
outer membrane (Alakomi et al., 2000), allowing other compounds to act synergistically with 
lactic acid (Niku-Paavola et al., 1999). 
 The mode of action of organic acids on bacteria is explained in figure 2.3.4. Non-
dissociated, or free, organic acids (RCOOH) can penetrate the bacterial cell wall, and thus enter 
the bacterial cytoplasm where they are exposed to a pH value near to neutrality (7.85 ± 0.05 for 
E. coli) and subsequently dissociate (Gauthier, 2002), releasing H+ and anions (A-). As a result of 
accumulating protons, the internal pH decreases. In case of non-pH sensitive bacteria (Figure 
2.3.4) under low internal pH conditions, the organic acids remain in the free acid form and thus 
exit the bacteria. This process forms equilibrium between internal and external pH and protects 
the bacteria from detrimental effects of pH fluctuations (Lambert and Stratford, 1999). A specific 
mechanism (H+ -ATPase pump) in pH-sensitive bacteria acts to bring the pH inside the bacteria 
back to a normal level, as they can not tolerate a large spread between the internal and the 
external pH. This process consumes energy and eventually stops the growth of the bacteria or 
even kills it. A lower cytoplasmic pH inhibits glycolysis, prevents active transport, and also 
interferes with signal transduction (Lambert and Stratford, 1999). Furthermore, the anionic (A-) 
part of the acid cannot diffuse freely through the cell wall, and thus accumulates inside the 
bacterial cell. Accumulation of anions leads to internal osmotic problems for the bacteria. 
 Complete inhibition of S. typhimurium SL1344 growth was observed due to a              
pH-lowering effect produced by L. acidophilus LAP5 strain (Fayol-Messaoudi et al., 2005). 
Makras et al. (2006) demonstrated an inhibitory effect of lactic acid produced by probiotic 
lactobacilli upon invasion of Salmonella into Caco-2/TC7 cells. Viability of Salmonella was 
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found to be decreased rapidly after 1 h (~2 logs) and dramatically after 3 h (~8 logs) in the 
presence of L. rhamnosus GG supernatant containing lactic acid (De Keersmaecker et al., 2006). 
 
Figure 2.3.4 Mode of action of organic acids (RCOOH) on, A) non pH-sensitive bacteria (Lactic 
acid bacteria, Bifidobacteria), B) pH-sensitive bacteria (Coliforms, Clostridia, Salmonella, 
Listeria spp.) (Adapted from Gauthier, 2002)  
 
 
Some LAB produce hydrogen peroxide (H2O2) under aerobic growth conditions and 
because of the lack of cellular catalase, pseudocatalase, or peroxidase, they release it into the 
environment to protect themselves from its antimicrobial action. It is a strong oxidizing agent 
and can oxidize the –SH group of membrane proteins of Gram-negative bacteria, which are 
especially susceptible (Ray, 2004). Lactobacillus gasseri CRL1421 and L. gasseri CRL1412 
 33 
were found to produce H2O2 and lactic acid in vitro, which reportedly reduced the viability of 
Staphylococcus aureus by 4 log units (P < 0.05), after 6 h of incubation (Otero and Macias, 
2006). 
2.3.4.5 Acylated homoserine lactones  
 Quorum sensing (QS) is a mechanism by which bacteria organize the expression of 
certain genes in response to their population density by producing, detecting and releasing small 
signal molecules. Quorum sensing was first observed in the marine bacterium, Vibrio fischeri 
(Nealson et al., 1970), an organism which undergoes bioluminescence under high cell densities. 
It has been demonstrated that inactivation of the QS system in pathogens can result in a 
significant decrease in virulence factor expression (Swift et al., 1997). Disruption of QS has 
become a new anti-infective strategy (Defoirdt et al., 2004). Acylated homoserine lactones 
(AHLs) are important intercellular signalling molecules used by many bacteria to monitor their 
population density in QS control of gene expression. These signalling compounds are the 
biochemical products of the LuxI family of proteins. AHLs acts as QS signal molecules in   
Gram-negative bacteria (Miller and Bassler, 2001) and small (oligo) peptides play this role in 
Gram-positive bacteria (Defoirdt et al., 2004). The family of autoinducers known as AI-2 
operate in both Gram-negative and Gram-positive bacteria. Recently, AI-2-like molecules have 
also been detected in the cell-free culture fluid of several LABs, including Lactobacillus 
rhamnosus GG (Dirix et al., 2004). Besides the autoinduction, the most common mechanism of 
QS in Gram-positive bacteria consists of an ATP-binding cassette (ABC) transporter for 
secretion of the peptide, and a two-component system for sensing of the autoinducer 
concentration. Whereas, QS in Gram-positive Staphylococcus aureus and Eenterococcus faecalis 
are the exceptions of the ABC mechanism, which use a non-ABC transporter to secrete the 
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autoinducer. The QS system in Bacillus subtilis further involves genetic competence and 
sporulation, in which the peptide, after a Sec-dependent secretion and extracellular processing, is 
imported into the cytoplasm by an oligopeptide transport system where it interacts with 
intracellular receptors (Dirix et al., 2004). Studies done by McClean et al. (1997) showed that QS 
pigment production in Gram-negative Chromobacterium violaceum was stimulated by naturally-
occurring AHL molecules. The acyl side chain has been found to be linked to the stimulatory and 
inhibitory effect of the AHLs. AHLs with an acyl side chain containing up to 8 carbon atoms 
were found to have a stimulatory effect and acted as QS agonists; whereas, acyl side chains 
containing 10 or more carbon atoms showed an inhibitory effect and acted as QS antagonists. A 
study done by Dong et al. (2002) suggested that enzymatic AHL inactivation could be used as a 
biocontrol strategy. In this study, expression of the AiiA (AHL-inactivating activity) enzyme in 
transformed Erwinia carotovora decreased the production of cell wall-degrading enzymes by the 
pathogen to about 10% and inhibited soft rot disease symptoms in susceptible plants almost 
completely.  
 A probiotic isolate, Lactobacillus fermentum RC-14, was reported to inhibit acute 
Staphylococcus aureus infection (Gan et al., 2002). The probiotic was found to secrete cell-
surface extracellular matrix-binding proteins and a biosurfactant which prevented pathogen 
adherence to surgical implants. These findings illustrate different potential microbial antagonistic 
mechanisms other than antibiotic production, such as signal interference, for the control and 
prevention of biofilm formation by pathogenic bacteria. 
2.4 Clinical evidence of probiotic efficacy 
 Metchnikoff (1907) was perhaps the first researcher to propose that fermented dairy 
products have beneficial properties. Various nutritional and therapeutic benefits (Table 2.4.1) to 
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the consumer were found to be associated with the consumption of lactic cultures and their 
fermented products (Danone, 2001; Parvez et al., 2006). The disorders hypolactasia, lactose 
malabsorption or maldigestion, and lactose intolerance, are characterized by a low concentration 
of the lactose cleaving enzyme lactase, or β-galactosidase, in the brush-border membrane of 
small intestinal enterocytes.  
 
Table 2.4.1 Various special therapeutic or prophylactic properties of specific probiotics (Adapted 
from Parvez et al., 2006) 
 
Microflora Associated actions 
Bifidobacteria spp. Reduced incidence  of enterocolotis 
Enterococcus faecium Decreased duration of acute diarrhoea  
Lactobacillus strains Efective in ameliorating pouchitis, decreased diarrhoea and 
symptoms of intolerence in lactose intolerent individuals, improved 
mucosal immune function, mucin secretion and prevention of disease 
L. acidophilus Significant decrease of diarrhoea in patients receiving pelvic 
irradiation, prevented uropatogens Escherichia coli, Klebsiella 
pneumoniae, Pseudomonas aeruginosa, lowered serum cholesterol 
evels 
L. plantarum Reduced incidence of diarrhoea and inflammation in inflammatory 
bowel, reduced bloating, pain and flatulence in irritable bowel 
syndrome, positive effect on immunity in HIV positive children 
L. reuteri Shortened the duration of acute gastroenteritidis and diarrhoea 
L. rhamnosus Enhanced cellular immunity in healthy adults in controlled trial 
L. salivarius Suppressed and eradicated Helicobacter pyroli in vitro and in vivo 
Bacteroides spp. Increased bacterial urease activity in chronic arthritis 
Saccharomyces 
boulardii 
Reduced Cl. difficile diarrhoea and antibiotic associated diarrhoea, 
shortened the duration of acute gastroenteritis 
 
 A significant proportion of the human population has some degree of intolerance to 
lactose. With the exception of the population of Northern and Central Europe, approximately 
85% of adults worldwide are lactose malabsorbers (Goktepe et al., 2006). The LAB has an 
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excellent capacity to metabolize lactose. Studies by Kolars et al. (1984) showed that, in lactase-
deficient subjects, lactose was absorbed significantly better from yogurt than from milk. Two 
different mechanisms of action have been put forward to explain this finding. Yogurt and 
probiotic LAB contain high levels of lactase, which is released within the intestinal lumen when 
these bacteria are lysed by bile secretions. Lactase then acts on the ingested lactose, thus 
relieving maldigestion symptoms. The reduced intestinal transit time of yogurt might also allow 
slower digestion of lactose. Several reviews (Rolfe, 2000; Kopp-Hoolihan, 2001; de Vrese et al., 
2001) have described that some probiotics could improve lactose digestion and eliminate the 
symptoms of intolerance. While mechanisms by which these probiotics exert their effects are not 
fully understood yet; they may involve modifying gut pH, expressing β-galactosidase, exerting 
positive effects on intestinal functions and colonic microbiota. In a systematic review by Levri et 
al. (2005), in contrast, it was concluded that probiotic supplementation in general did not 
alleviate the symptoms of lactose intolerance in adults. The lactose contained in yogurts can be 
considered as a prebiotic for people with lactose maldigestion (Szilagyi, 2004). Regular 
consumption of lactose influences their colonic microbiota and reduces lactose intolerance 
(Hertzler and Savaiano, 1996). 
 One particular strain, Lactobacillus casei DN-114001, has been reported to reduce 
diarrhoeal morbidity by 40% in children (Agarwal and Bhasin, 2002). Study on pregnant women 
and newborns suggested that consumption of probiotic L. rhamnosus GG reduced the rate of 
newborns having atopic dermatitis (Kalliomaki et al., 2001).  
In an Australian study, 178 newborns of women with allergies who received either              
L. acidophilus LAVRI-A1 or placebo daily for the first 6 months of life showed no difference in 
atopic dermatitis (probiotic, 23/89 versus placebo, 20/88; P = 0.629). However, at 12 months, the 
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rate of sensitization was significantly higher in the probiotic group (P = 0.030). These results 
suggested that the probiotic treatment has increased the risk of subsequent cow’s milk 
sensitization (P=0.012) (Taylor et al., 2007). Similarly, a double-blind, randomized, placebo-
controlled trial study was conducted by Abrahamsson et al., (2007) on 188 subjects with allergic 
disease, in which the mothers received Lactobacillus reuteri ATCC 55730 daily from gestational 
week 36 until delivery, and their babies continued with the probiotic until 12 months. Probiotic 
supplemented babies showed less IgE-associated eczema during the second year. 
2.5 Prebiotics 
 Association of colonic microflora with beneficial health effects is now well established. 
Consequently, the use of prebiotics as functional food ingredients to manipulate the composition 
of colonic microflora to improve health is currently a growing interest (Wang, 2009). According 
to Solange et al., (2007) prebiotics are non-digestible carbohydrates (oligosaccharides) of low 
molecular weight and intermediate in nature between simple sugars and polysaccharides. 
Resistant short-chain carbohydrates (SCCs) are also referred to as non-digestible 
oligosaccharides or low digestible carbohydrates (LDCs) (Cummings et al., 2001). Prebiotics are 
defined as “selectively fermented ingredients that allow specific changes, both in the 
composition and/or activity in the gastrointestinal microbiota that confers benefits upon host 
well-being and health” (Wang, 2009). Prebiotics resist hydrolysis and absorption in the upper 
parts of the GIT and may selectively be metabolized by at least one type of probiotic 
microorganism in the colon, leading to growth and/or metabolic activation of the probiotic 
microorganisms, improvement of the colonic flora, and beneficial luminal or systemic effects for 
the health of the host (Gibson and Roberfroid, 1995). Bifidobacteria and lactobacilli are the most 
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important bacterial genera targeted for selective stimulation by prebiotics (Teitelbaum and 
Walker, 2002). The “bifidogenic” effects of SCC or LDCs make it possible for their inclusion 
into conventional food products (Holzapel et al., 1998). Oligosaccharides that have been 
considered as prebiotics include galacto-oligosaccharides, isomalto-oligosaccharides, soybean-
oligosaccharides, lactosucrose, and xylo-oligosaccharides (Rastall and Gibson, 2002). For the 
comparison of prebiotic effects of dietary oligosaccharides, a quantitative prebiotic index (PI) 
equation has been developed by Palframan et al. (2003). This equation is based on the changes in 
key bacterial groups like bifidobacteria, lactobacilli, clostridia and bacteroides during 
fermentation. The changes in bacterial groups from previous studies were entered into the 
equation in order to determine a quantitative PI score. Table 2.5.1 shows examples of prebiotics 
used for human consumption (Wang, 2009). 
Table 2.5.1 Examples of ingredients that are commonly regarded as human prebiotics (Wang, 
2009) 
 
Prebiotics 
Inulin-type fructans 
Trans-galactooligosaccharides (TOS) 
Lactulose 
Isomalto-oligosaccharides 
Lactosucrose 
Xylo-oligosaccharides 
Soybean-oligosaccharides 
Gluco-oligosaccharides 
Fructo-oligosaccharides (FOS) 
Galacto-oligosaccharides (GOS) 
2.5.1 Inulin and fructo-oligosaccharides (FOSs) as prebiotics 
 Inulin and FOSs are considered as typical “bifidogenic factors” and are probably the most 
commonly-used prebiotics in the market (Bouhnik et al., 1999). Growth of L. casei was 
significantly (P ≤ 0.05) higher when inulin of different chain lengths was incorporated at a 
concentration of 1.5 g/100 g yogurt mix (Aryana et al. 2007). Similarly a study by Akalin et al. 
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(2004) reported higher counts of Bifidobacterium longum (106 cfu/g) and Bifidobacterium 
animalis (3.59-2.25 × 107 cfu/g) in yogurts containing FOS during 28 days storage at 4°C; 
whereas, this level was maintained for only 7 days in yoghurt without any prebiotic. Scientific 
studies done in Japan showed that the consumption of FOS in the diet increases the population of 
bifidobacteria and other beneficial micro-organisms, even in the absence of probiotics (Losada 
and Olleros, 2002). Similarly, increased numbers of lactobacilli and bifidobacteria were found 
following the consumption of FOS in a study by Mitsuoka (1990). To assess the effects of 
lactulose administration on faecal bifidobacteria, a controlled, randomised, double-blind, and 
parallel group trial study was conducted on 16 healthy volunteers by Bouhnik et al. (2004). 
Participants ingested lactulose or placebo (sucrose) at a dose of 5 g twice a day for 6 weeks. 
Results showed that ingestion of 10 g of lactulose per day increased fecal bifidobacterial counts 
from day 0 to day 42 (8.25 ± 0.53 to 9.54 ± 0.28 log cfu/g wet weight, respectively). Shin et al. 
(2000) reported a decrease in mean doubling time and increase in viability of Bifidobacterium 
spp. (Bf -1 and Bf -6) in skim milk during 4 weeks of storage at 4°C, containing inulin, fructo-
oligosaccharides (FOS) and galacto-oligosaccharides (GOS) at a concentration of 50 g/L. A 67% 
viability of Bf-1 and 45% viability of Bf-6 were retained in the presence of FOS. When grown in 
the presence of GOS, 52 and 39% retention of viability of Bf-1 and Bf-6 was observed, 
respectively. Inulin was the least effective (P < 0.05) in retaining viability of either strain.  
2.5.2 Health benefits of prebiotics 
 A number of beneficial effects are associated with prebiotics, including the favorable 
influence on the small bowel by improved sugar digestion and absorption, glucose and lipid 
metabolism, and protection against known risk factors of cardiovascular diseases (Bruzzese et 
al., 2006) as shown in Table 2.5.2.  
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Table 2.5.2 Microbiological changes reported in human feeding studies with prebiotics (Adapted 
from Macfarlane et al., 2008) 
 
Substrate Type of study Delivery Effect on microbiota 
GOS Placebo controlled 
study involving 12 
subjects 
10 g prebiotic fed daily for 8 
weeks 
Faecal excretion of bifidobacteria 
and lactobacilli increased 
    
 Feeding study with 
12 subjects 
2.5 g prebiotic given per day 
for 3 weeks 
Increased bifidobacteria in faeces, 
reductions in numbers of 
clostridia and bacteroides 
    
TOS Feeding study with 8 
volunteers 
Subjects given 10 g TOS for 
3 weeks 
Significant increases in faecal 
bifidobacteria, enterobacteria 
unaffected 
    
 Parallel study 
involving 40 healthy 
subjects 
7.5 or 15 g prebiotic fed per 
day for 3 weeks 
Lactobacilli increased in 15 g/day, 
no effects on clostridia, small 
reductions in enterobacteria 
    
GOS ⁄ FOS Placebo-controlled 
study with 90 term 
infants 
Infant formula 
supplemented with either 4 
or 8 g/l low molecular 
weight GOS and high 
molecular weight FOS for 
28 days 
Significantly increased 
lactobacilli and bifidobacteria in 
the two GOS feeding groups. 
    
GOS Placebo-controlled 
study involving 30 
subjects 
Volunteers given 8.1 g GOS 
syrup, 8.1 g GOS plus 3 X 
1010 Bifidobacterium lactis 
Bb-12, or 3 X 1010 B. lactis 
without GOS for 3 weeks 
Little change in faecal 
bifidobacteria seen with GOS 
alone. GOS plus B. lactis and B. 
lactis on its own resulted in faecal 
excretion of the organism and 
reduced numbers of B. longum. 
    
GOS ⁄ FOS(9 :1 ratio) Double-blinded, 
randomized 
controlled trial 
(DBRCT) involving 
20 infants aged 28–
90 days 
Infant formula 
supplemented with 0.8 g 
/100 ml GOS ⁄ FOS for 6 
weeks 
Increased total bifidobacteria 
counts in stools. Reduced B. 
adolescentis compared to standard 
infant formula controls. 
Bifidobacteria spp. composition in 
prebiotic infants similar to that 
found in breast-fed babies, with B. 
infantis, B. breve and B. longum 
predominating 
    
GOS ⁄ FOS (9:1 ratio) Feeding study 
involving 42 preterm 
infants, 15 placebos, 
and a reference group 
given fortified 
mothers milk 
Formula food supplemented 
with 10 g/l prebiotic mixture 
Bifidobacteria numbers greatly 
increased from initially low 
levels, compared to un-
supplemented controls. No 
significant effects on bacteroides, 
clostridia, enterobacteria or yeasts 
 
 
 41 
Various in vivo and in vitro studies shows health benefits of prebiotics such as FOS and GOS 
alone, or in combination with inulin (Macfarlane et al., 2008). Production of short chain fatty 
acids (SCFAs) is considered to be a major beneficial feature related to the primary prevention of 
colorectal cancer (Scheppach et al., 2001). SCFAs and lactic acid are produced as a result of 
metabolism of FOS by fermentative bacteria, leading to a drop in the pH of the large intestine. 
Low pH conditions were reported to be ideal for growth of bifidogenic flora. A study done by 
Liu et al. (2004) on 55 cirrhotic patients, were randomized to receive a probiotic plus prebiotic 
(synbiotic) preparation containing 4 freeze-dried probiotics namely Pediacoccus pentoseceus, 
Leuconostoc mesenteroides, L. paracasei subsp. paracasei and L. plantarum. Each probiotic was 
given at a dose of 1010 cfu/sachet, along with 10 g of bioactive, fermentable fiber (beta glucan, 
2.5 g; inulin, 2.5 g; pectin, 2.5 g; resistant starch, 2.5 g) (n = 20), fermentable fiber alone (n = 
20), or placebo (n = 15) for 30 days. The controls had significant fecal overgrowth of potentially 
pathogenic E. coli and Staphylococcus spp., while the synbiotic treated subjects had significantly 
increased fecal content of Lactobacillus strains. 
2.6 Viability of probiotic microorganisms 
 Fermented dairy products such as milk and yogurt are the most accepted food carriers for 
live probiotic delivery to the human GIT. A recommended intake of probiotics is 108-109 viable 
live cells daily (Lourens-Hattingh and Viljoen, 2001) in order to get the beneficial health effects. 
Standards have been made in many countries for the numbers of viable probiotic bacteria that are 
present in commercial fermented products. For example, in Japan, fermented milks and LAB 
containing beverages must contain a minimum of 107 cfu/mL or gram of product (Robinson, 
1987). Despite the importance of viability of these beneficial bifidobacteria, surveys have shown 
poor viability of bifidobacteria in yoghurt preparations (Akalin et al., 2004). Several factors, like 
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acidity of the product, post acidification (acid produced during storage), level of oxygen in the 
products, sensitivity to antimicrobial substances produced by bacteria, temperature of storage 
during manufacture and storage of yoghurt, have been found to reduce the viability of probiotics 
(Lankaputhra and Shah, 1995; Dave and Shah, 1997). Thus, maintaining viability of 
bifidobacteria until the products are consumed in order to ensure the delivery of live organisms 
has been of much interest. 
2.6.1 Influence of cryoprotectants 
 Freeze-drying is a preservation process that has been employed to improve the survival of 
probiotic microorganisms (Rybka and Kailaspathy, 1995). Survival and rapid growth after 
freezing is one of the most important characteristics for the selection of probiotics because they 
are most often delivered in the form of frozen dairy desserts. Addition of compatible 
cryoprotectants into the media or yogurt mix prior to fermentation has been shown to improve 
the viability of probiotic microorganisms (Kets et al., 1996). Improvement in the viability of 
probiotics may occur as the cryoprotectants inhibit the formation of intracellular or extracellular 
ice by binding to the water (Capela et al., 2006). The cryoprotectant UnipectineTM RS 150 was 
found to improve the number of viable L. acidophilus 33200, L. casei 279, B. longum 536 and   
L. rhamnosus (GG) by 1 log during storage in fermented dairy desserts (Shah and Ravula, 2000). 
In another study, an 80% improvement in the survival of B. longum 536 was found by using 
UnipectineTM RS 150 (Capela et al., 2006).  
2.6.2 Encapsulation 
 Encapsulation is a process whereby cells are retained within an wall material to reduce 
cell injury. Encapsulation in hydrocolloid beads has been investigated as a means to protect and 
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improve viability of probiotic microorganisms in food products and in the intestinal tract (Rao et 
al., 1989). Other benefits of encapsulation includes: protection of probiotics from bacteriophage 
(Steenson et al., 1987), increased survival during freeze-drying and freezing (Kim et al., 1995), 
and greater stability during storage (Kebary et al., 1998). Hou et al. (2003) demonstrated that 
encapsulation of Lactobacillus delbrueckii spp. bulgaricus increased their bile tolerance, and 
viability was elevated by approximately four log units after encapsulation within artificial 
sesame oil emulsions. Capela et al. (2006) found improved viability of probiotic organisms 
encapsulated in 3% v/w sodium alginate in freeze-dried yogurt after 6 months of storage at         
4 (~8 log cfu/g) and 21°C (~6 log cfu/g). Spray drying, freeze drying, fluidized bed drying are 
techniques which are used for converting probiotic cultures into a concentrated powdered form. 
However, these techniques do not protect the bacteria from the product environment or during 
their passage through the GIT because they release the bacteria completely into the product. The 
viability of Bifidobacterium bifidum BB-12 and L. acidophilus LA-5 encapsulated in Na-alginate 
by either an extrusion or an emulsion technique and used in white-brined cheese was monitored 
(Ozer et al., 2009). Both encapsulation techniques were found to be effective in keeping the 
numbers of probiotic bacteria higher than the level of the therapeutic minimum (>107 cfu/g). 
While the counts of non-encapsulated probiotic bacteria decreased approximately by 3 logs, the 
decrease was more limited in the cheeses containing microencapsulated cells (approximately       
1 log). 
Depending on the method used to form the beads, the encapsulation techniques applied 
for probiotics for use in fermented milk products or biomass production can be classified as 
either the: i) extrusion or droplet method, and ii) emulsion or two phase systems (Figure 2.6.1). 
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Both techniques have been found to increase the survival of probiotic bacteria by up to 80-95% 
(Audet et al., 1988; Rao et al. 1989). 
2.6.2.1 Extrusion technique 
 In extrusion encapsulation, microorganisms are added into a hydrocolloid solution 
(alginate) and then the cell suspension is extruded through a syringe needle to form droplets, 
which free-fall into a hardening solution or setting bath (Figure 2.6.1).  
MIX
Emulsification in 
vegetable oil
Sodium alginate
Extrusion
Emulsion
Cell suspension
CaCl2
Cell suspension
Microbial cell
Liquid core
CaCl2 solution
Calcium alginate bead
 
Figure 2.6.1 Flow diagram of encapsulation of bacteria by the extrusion and emulsion techniques 
(Reproduced from Krasaekoopt et al., 2003) 
 
The size and shape of the beads depends on the diameter of the needle and the distance of 
free-fall (Kim, 1995). Alginate is used commonly as supporting material in this technique. The 
concentrations of alginate used to form the gel varies from a very low concentration of 0.6% to 
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form a gel with 0.3M CaCl2 to 1–2% alginate and 0.05–1.5M CaCl2 (Krasaekoopt et al., 2003). 
The size and sphericity of the bead also depends on the viscosity of the sodium alginate solution, 
the distance between the syringe and the calcium chloride collecting solution and the extruder 
orifice diameter. As the concentration of sodium alginate increases, the size of the beads 
decreases. Using a 0.27 mm syringe resulted in a bead size of 2–3 mm. The composition of the 
alginate also influences bead size; small beads result from ‘‘low guluronic’’ alginates 
(Krasaekoopt et al., 2003).  
2.6.2.2 Emulsion technique 
 In the emulsion technique, a small volume of the cell-polymer suspension (the 
discontinuous phase) is added to a large volume of a vegetable oil (e.g. canola or corn oil). The 
mixture is homogenized to form a water-in-oil emulsion. Once formed, the water-soluble 
polymer must be insolubilized (cross-linked) to form tiny gel particles within the oil phase 
(Figure 2.6.1). The smaller the internal phase particle size of the emulsion, the smaller the final 
microparticles will be. The supporting material used in this technique may include κ-carageenan 
and locust bean gum (Audet et al., 1988), cellulose acetate phthalate (Rao et al., 1989), alginate 
(Sheu and Marshall, 1991), chitosan and gelatin (Groboillot et al., 1993). 
2.7 Synbiots 
 The combination of a probiotic and prebiotic is referred to as a synbiot. Synbiots have 
been shown to confer health benefits beyond those of either on its own. Rowland et al. (1998) 
showed the enhanced reduction in the number of colonic aberrant crypt foci, as well as colon 
carcinogenesis in rats (Gallaher and Khil, 1999). Antibiotic-associated diarrhea was found to be 
prevented by the combined application of Lactobacillus sporogenes and FOS in children (Rosa 
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et al., 2003). Synbiotic combination of L. paracasei and maltodextrin was found to decrease the 
colonization of E. coli in the jejunum of piglets. This symbiotic combination led to an increase in 
lactobacilli and bifidobacteria and decreased clostridia and enterobacteria (Bomba et al., 2002). 
On the other hand, Anderson et al. (2004) did not find any improvement of gut barrier function 
in surgical patients following synbiotic therapy.  
 Therefore, further investigation is needed to continue, and extend our understanding of 
probiotics, along with the efficacy once encapsulated. The present research investigates the 
ability of probiotic bacteria to survive in simulated gastric conditions of the GIT, as well as their 
ability to become established on the surface of the intestinal epithelium or to other resident 
microflora. An attempt was made to determine the antimicrobial potential of the probiotic 
bacteria against a panel of selected enteric pathogens. The probiotic bacteria were also 
characterized using biochemical techniques to aid in their identification during follow-up 
research. Model HCl/bile-based model gastric systems were then be used to compare the effect 
of encapsulation on the survival of the probiotic bacteria. 
 
 
 
 
 
 
 
 
 47 
3 In vitro characterization of probiotic survival, adherence and antimicrobial resistance: 
candidate selection for encapsulation in a pea protein isolate-alginate delivery system 
Abstract 
 A panel of probiotic strains, including Lactobacillus acidophilus ATCC 11975, 
Bifidobacterium infantis ATCC 15697D, B. catenulatum ATCC 27675 and B. adolescentis 
ATCC 15703, were screened for a number of traits, including their resistance to acid and bile and 
adherence to Caco-2 cells. Under simulated gastric conditions (pH 2.0), L. acidophilus was the 
most acid-tolerant strain (D-value 10.2 ± 0.8 min), and was able to survive for 30 min; whereas, 
the other probiotics tested underwent a rapid (within the first 5 min at pH 2.0) 4-5 log cfu/mL 
loss in viability. Notably, the number of viable L. acidophilus decreased by less than 1 log 
cfu/mL over the same interval. All probiotics tested were able to survive 5 h of exposure to 0.3% 
(w/v) Oxgall bile at pH 5.8. The relative ranking of probiotic adherence to Caco-2 cells was 
determined to be: L. acidophilus > B. catenulatum > B. adolescentis > B. infantis, which 
correlated with 4.5  104, 3.1  103, 2.6  101, and 1.5  101 cfu/mL associated with Caco-2 cell 
monolayers, respectively.  The probiotics also revealed varying degrees of resistance for the 
antimicrobial agents: ciprofloxacin, naladixic acid, kanamycin and sulfisoxazone. Determination 
of carbon source utilization patterns indicated that all strains grew to the highest culture optical 
densities on D-xylose. L. acidophilus was determined to be the best overall in vitro performer, 
and hence was selected for encapsulation within a ~3 mm diameter pea protein-alginate matrix.  
Upon exposure of encapsulated L. acidophilus to simulated gastric conditions (pH 2.0) there was 
only a ~1 log cfu/mL loss of cell viability observed over a 2 h period; whereas, unprotected L. 
acidophilus cells experienced a reduction in cell viability of greater than 6 log cfu/mL over the 
same period. The present study indicates that the encapsulated delivery of probiotics is a feasible 
means for enhancing probiotic survival during passage through the upper gastrointestinal tract.   
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3.1 Introduction 
 Probiotics are microorganisms that are consumed orally and that reach the GIT in a viable 
state, where they subsequently contribute to the beneficial activity of intestinal microflora and, 
thus, to the health of its host. Most probiotic bacteria are LAB and among them lactobacilli and 
bifidobacteria reportedly play a significant role in maintaining the intestinal microbial ecosystem 
and in stimulating the immune system of the host (Saarela et al., 2002). Finegold et al. (1977) 
demonstrated that while lactobacilli were not the predominant species among the intestinal 
microflora, they were commonly isolated from the GITs of healthy humans. Others have shown 
that typical numbers of endogenous faecal lactobacilli per gram of faeces ranged from 105 to 108 
cfu (Kimura et al., 1997; Holzapfel et al., 1998).  
 It has been shown that the functional and technical properties of probiotics are strain-
specific, and thus it is necessary to screen various isolates for a variety of in vitro properties to 
obtain new probiotic candidates is of utmost important (Collins et al., 1998; Ouwehand et al., 
2002). These include general aspects (e.g., origin, identity, resistance to mutations, resistance to 
environmental stress prevailing in the GIT such as low pH, bile acid and pancreatic juice), 
technical considerations (e.g., in vitro growth and processing properties), functional and 
beneficial properties (e.g., adhesion and colonization to intestinal mucosa, competitiveness, 
antagonism against pathogens, and stimulation to immune response) and safety concerns (e.g., no 
invasive potential, no transferable resistance against therapeutic antibiotics and no virulence 
factors) (Holzapfel et al., 2002). Lactobacilli fulfill these criteria (Dunne et al., 2001) and their 
use is now being supported by clinical benefits (Reid et al., 2003).  Cellular stress on probiotics 
begins in the stomach, where pH values as low as 1.5 are typically encountered (Lankaputhra 
and Shah, 1995). Following passage through the stomach, probiotics come in contact with bile in 
the upper intestinal tract, the concentration of which is variable and difficult to predict at any 
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given time (Northfield and McColl, 1973). After traveling through these relatively harsh 
conditions, the probiotic should ideally adhere to the lower intestinal tract epithelia and 
microflora where it would proliferate as a stable member (Conway et al., 1987), so that they are 
able to exert health benefits to the host for prolonged periods. It is noteworthy that some 
conjecture presently exists as to whether all probiotics must actually colonize the epithelial 
membranes of the intestine for a probiotic effect to be realized.  
While there continues to be a lack of clear information to the biologically-effective 
probiotic dose, it is clear that increasing the number of viable probiotic that reach the upper GIT 
is important.  Improved survival of probiotics exposed to the low pH gastric environment (Rao et 
al., 1989; Wenrong and Griffiths, 2000) and bile salts (Lee and Heo, 2000), molecular oxygen in 
the case of obligatory anaerobic microorganisms, bacteriophages (Steenson et al., 1987), 
chemical antimicrobials (Sultana et al., 2000), and increased survival during freezing and freeze 
drying (Shah and Rarula, 2000) have all been reported following probiotic microencapsulation. 
Additional advantages of probiotic encapsulation over free cells include an increase of sensory 
properties, stability (Gomes and Malcata, 1999), and immobilization of the cells for their 
homogeneous distribution throughout the product (Krasaekoopt et al., 2003). A variety of 
substrates have been employed as encapsulating materials for entrapping live microorganisms, 
including alginate, whey protein, pea protein, gelatin, methylcellulose, etc. (Sheu et al., 1993; 
Prevost and Divies, 1988; Gombotz and Wee, 1998; Pierucci et al., 2007). Among these, 
alginate-gel beads have frequently been used for the immobilization of LAB (Sheu et al., 1993), 
as it is an accepted food additive and has the benefit of being nontoxic to the cells being 
immobilized (Prevost and Divies, 1988). 
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The objective of present study was to conduct in vitro screening of a panel of probiotic 
organisms, using acid resistance, bile toxicity and ability to attach to the human intestinal cells, 
as test variables.  Probiotics were also screened for resistance to commercial antibiotics and their 
ability to utilize different sole carbon sources. Based on the above tests, a candidate probiotic 
was selected for encapsulation in a pea protein-alginate matrix and then challenged with 
simulated gastric conditions.  
3.2 Materials and methods 
3.2.1  Bacteria and culture conditions 
The probiotic strains Lactobacillus acidophilus ATCC 11975, Bifidobacterium infantis 
ATCC 15697D, B. catenulatum ATCC 27675 and B. adolescentis ATCC 15703 were stored at    
-80ºC using 10% glycerol amended in culture broth as a cryoprotectant. DeMan Rogosa and 
Sharpe (MRS) broth (VWR, Mississauga, ON, Canada) was used as a media for routine 
cultivation of lactobacilli; whereas, MRS supplemented with 0.05% (w/v) L-cysteine HCl was 
used for cultivation of bifidobacteria. Prior to each experiment, stock cultures were propagated 
twice in sterile broth under anaerobic conditions (10% H2, 10% CO2, and 80% N2) at 37°C for 24 
h to provide inocula for subsequent experiments. Inocula of each strain were harvested at the 
early stationary phase of growth (~ 20 h; data not shown) by centrifugation at 3,250 × g (Model 
5810 R with swing-bucket rotor A-4-81; Eppendorf, Hamburg, Germany) for 10 min at 4C.  
Cells were then washed twice with phosphate-buffered saline (PBS; 4.3 mM Na2HPO4.7H20, 
137.0 mM NaCl, 2.7 mM KCl, 1.4 mM KH2PO4, pH 7.2) and resuspended in peptone saline  
(PS; 8.5 g/l NaCl, 1.0 g/l peptone, pH 7.0). 
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3.2.2 Probiotic resistance to simulated gastric juice (SGJ) 
Probiotic resistance to SGJ was performed according to the following experimental 
design; washed cell suspensions (~105 cfu/mL) were inoculated in triplicate into SGJ without 
pepsin (0.08 M HCl containing 0.2% w/v NaCl) with pH adjusted to 2.0 and 6.0 (control) using 
either HCl or NaOH. Samples were mixed well, incubated at 37C and aliquots removed every 5 
min for 2 h and serially diluted in PS. Surviving bacteria were enumerated by pour plating. D-
values for each probiotic were calculated for the 0 to 5 min. SGJ exposure period using the 
equation, D = t / n where n = (log N0-log Nt) = 1 log10 reduction of the cell number,    D = 
Decimal reduction time (min) at pH 2.0, N0 = bacteria at 0 time; Nt = surviving bacteria after an 
exposure time, t (min). The best surviving probiotic at pH 2.0 will be tested for its survival at pH 
4.0 and 5.0.  
3.2.3 Probiotic resistance to bile salts 
The method of Gilliland et al. (1984) was used to evaluate the growth potential of the 
four probiotic strains in broth media with and without Oxgall bile salts (Sigma-Aldrich Inc.,     
St. Louis, MO, USA). Accordingly, MRS broth without (control) and with 0.3% bile (w/v) was 
inoculated with 100 µL (~106 cfu/mL) of each overnight culture, and then incubated under 
anaerobic conditions for 24 h at 37ºC and 100 rpm shaking. Growth was monitored hourly by 
measuring absorbance at 600 nm using a spectrophotometer. Experiments were conducted in 
triplicate.  
Survival of the different probiotic strains in the presence of 0.3% Oxgall was monitored 
by the standard plate count method. Overnight cultures were inoculated into flasks containing 
sterile MRS (control) and MRS-bile, and incubated at 37C for 5 h, anaerobically. Aliquots were 
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removed every hour and serially diluted in PS. Surviving bacteria were enumerated by spread 
plating. 
3.2.3.1 Microscopy 
An inverted light microscope (Nikon Eclipse, TS100; 400 X NA 0.55 lens) was used to 
take photographs of crystals formed by probiotic bacteria in the MRS broth containing 0.3% bile 
and MRS broth without any added bile (control).  
3.2.4 Probiotic adherence to Caco-2 cell lines 
3.2.4.1 Cell culture 
Enterocyte-like Caco-2 cells were kindly provided by Dr. Wolfgang Köster (Vaccine 
Infectious Disease Organization (VIDO), Saskatoon, Canada). Caco-2 cells were routinely 
cultured at 37ºC in 5% CO2-95% air atmosphere in Dulbecco Modified Eagle’s Minimal 
Essential Medium (DMEM; Aldrich Sigma, ON) supplemented with 10% heat-inactivated fetal 
bovine serum (Invitrogen Canada Inc., Burlington, ON). Caco-2 cell monolayers were used for 
the probiotic adherence assay at the post-confluence stage (after 10 d). The concentration of 
Caco-2 cells in the monolayer was determined by trypsinizing the cells using Trypsin-EDTA for 
10 min at 37ºC followed by counting in a hemocytometer. Caco-2 cells (50 to 52 passages) were 
seeded at a concentration of 3  104 cells/mL in sterile 24-well tissue culture plates. The culture 
medium was changed every 2 d.  
3.2.4.2 Adhesion assay 
Adhesion assay was conducted as outlined by Jacobsen et al. (1999) and Pennacchia et al. 
(2006), as briefly outlined below. Post-confluence Caco-2 monolayers were gently washed two 
times with Hank’s Balanced Salt (HBS) solution (Invitrogen Canada Inc., Burlington, ON). 
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Probiotic bacteria in their early stationary phase of growth (~20 h; data not shown) were 
harvested and washed twice with PBS by centrifugation at 3,250 × g (Model 5810 R equipped 
with a swing-bucket rotor A-4-81; Eppendorf) for 10 min at 4C and diluted (10x) with DMEM 
to provide a bacterial concentration of ~5  105 cfu/mL. A 2 mL aliquot of each bacterial culture 
was used to inoculate the tissue culture plate wells containing Caco-2 cells, followed by 
incubation at 37ºC in 5% CO2-95% air atmosphere for 2 h. Control wells contained                  
un-inoculated DMEM. The viability of probiotic strains was also monitored in 5% CO2-95% air 
atmosphere for 2 h. Following incubation, Caco-2 cell monolayers were washed 5 times with 
HBS solution to release unbound bacteria. Washed Caco-2 cell monolayers were trypsinized 
using Trypsin-EDTA for 5 min at 37C to detach the bacterial cells from Caco-2 cells. The 
number of viable adhering bacteria was determined by spread plating serial 10-fold dilutions on 
MRS agar and incubating at 37C for 48 h under anaerobic conditions. 
3.2.5 Probiotic susceptibility to antibiotics 
Antibiotic resistance of each probiotic strain was determined using the Sensititre 
CMV1AGNF plates (Trek Diagnostic Systems, Inc., Westlake, OH, USA) that contained          
17 antimicrobial agents incorporated in dehydrated form into the wells of a plastic microtiter 
plate in either single or paired concentrations, as specified by the NARMS (National 
Antimicrobial Resistance Monitoring System) protocol of the CDC. Inocula for the antibiotic 
sensitivity assays was prepared by suspending isolated colonies of each probiotic (picked from 
fresh cultures on MRS agar plates incubated anaerobically for 48 h at 37°C) in a tube with 5 mL 
of sterile distilled water to an optical density of 0.5 McFarland standard, and subsequently 
diluting 1:100 in MRS broth. A 50 µL aliquot of this MRS broth suspension (containing ~106 
cfu/mL) was then transferred to each microtiter plate well. The plates were sealed and incubated 
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anaerobically at 37°C for 48 h (Klare et al., 2005; Doern et al., 1985), and then examined 
manually for the presence of turbidity. A ‘susceptibility category’ test result was assigned to 
each antimicrobial, as outlined below. With antimicrobials present in paired concentrations, 
turbidity in both wells was considered ‘resistant’, turbidity only in the well containing the lower 
concentration was considered ‘intermediate’, and absence of turbidity in either well was 
considered ‘susceptible’. For antimicrobials present in individual concentrations, turbidity was 
considered ‘resistant’ and absence of turbidity was considered ‘susceptible’. The minimum 
inhibitory concentration (MIC) breakpoints were determined according to the national committee 
for clinical laboratory standards (NCCLS, 2002a; and NCCLS, 2002b). 
3.2.6 Probiotic carbon source utilization profiles 
Biolog Ecoplates (Biolog, Inc., Hayward, CA, USA) contain 31 different sole carbon 
sources and can be used to screen substrate preference amongst different pure cultures. Cultures 
grown on solid MRS agar media for 48 h were swabbed and resuspended in sterile distilled 
water. The turbidity of these culture suspensions were then compared with the Biolog GP 
microplate turbidity standard (~108 cfu/mL). Biolog Ecoplate wells were subsequently inoculated 
with 150 µl of each cell suspension. Following an initial (time 0) reading, Biolog plates were 
incubated anaerobically at 37ºC for 48 h.  The substrate utilization patterns were analyzed with a 
microplate reader at a wavelength of 590 nm. 
3.2.7 Growth experiments 
Test was conducted according to Vernazza et al., 2006. Basal medium was prepared as follows:  
in g/L peptone water (Sigma chemicals company, Poole, UK) 2.0, yeast extract (Oxoid Ltd, 
Hampshire, UK) 2.0,  NaCl  0.1, K2HPO4 (Oxoid Ltd, Hampshire, UK) 0.04, KH2PO4 (Oxoid 
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Ltd, Hampshire, UK) 0.04, MgSO4.7H2O 0.01, CaCl2 2H2O 0.01, NaHCO3 2.0, Tween 80 (BDH 
chemicals, Poole, UK) 2.0 mL/L, hemin (Sigma chemicals company, Poole, UK) 0.005, vitamin 
K1 10 µL/L, Cysteine-HCl 0.5, bile salts (Oxoid Ltd, Hampshire, UK) 0.5, pH 7.0. Test 
carbohydrate solutions including D-lactose (BDH chemicals, Poole, UK), methyl-D-glucoside 
(NB Co. Cleveland, Ohio), D-xylose (Sigma chemicals company, Poole, UK) D-cellobiose 
(Sigma chemicals company, Poole, UK) and D-glucose (BDH chemicals, Poole, UK) were 
prepared (100 g/l). Test carbohydrate solution (1 ml) was added in 9 ml sterilized basal media. 
Bacteria were grown on MRS agar plates at 37°C for 48 h, and a single colony was added in 
basal media containing different carbohydrates. Each tested bacteria were subcultured twice in 
identical medium. Growth of test cultures was monitored for 48 h by measuring absorbance at 
600 nm using a spectrophotometer.  
3.2.8 Encapsulation of L. acidophilus 
 Pea protein isolate (4.0% w/v; PPI) + alginate (0.5% w/v; AL) capsule was prepared by 
dissolving 40.0 g/L PPI in 0.1 M NaOH under constant mechanical stirring, and heating at 80ºC 
for 30 min before cooling to 40ºC in a water bath. Once cooled, the solution was then neutralized 
to pH 7.0 with 1.0 M HCl and 5.0 g/L AL powder was then dispersed into the solution. The 
biopolymer mixture was then heated at 80ºC for another 30 min, before being cooled to 40ºC in a 
water bath. The weights of the solutions were corrected for water loss during heating. A 
suspension containing 1.0 g washed L. acidophilus (~108 cfu/mL) was mixed with 18.0 g of the 
4.0% PPI + 0.5% AL solution held at 40ºC and injected through a 20 G needle into 30 mL of 
filter sterilized 5.0% CaCl2 + 1.0% (w/v) Tween 80 crosslinking bath. The resultant capsules 
were allowed to harden in the cross-linking solution for 30 min, and then washed three times 
with PS. 
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3.2.9 Survival of encapsulated L. acidophilus in SGJ  
The survival of free and encapsulated L. acidophilus cells in SGJ (0.08 M HCl with 0.2 
% (w/v) NaCl) were studied at pH 6.0 and 2.0, as described below. Aliquots of 0.5 mL of free 
and encapsulated L. acidophilus cells in PS were added to 9.5 mL of SGJ at 37ºC and incubated 
anaerobically. Samples containing SGJ at pH 6.0 were removed at 20 min intervals over the 2 h 
assay period; for samples containing SGJ at pH 2.0, tubes were removed at 5 min time intervals 
over the first 30 min, and thereafter at 30 min intervals until 2 h. Tubes containing SGJ at pH 2.0 
were neutralized with 1.0 M NaOH upon removal from incubation. The contents of the tubes 
containing the encapsulated cells were homogenised (ES, Omni International Inc., Marietta, GA, 
USA) at a setting of 4.5 for 30s, serially diluted in PS and surviving bacteria enumerated by pour 
plating using MRS media. The plates were incubated under anaerobic conditions at 37ºC for 48 
h. Experiments were conducted in triplicate. 
3.2.10 Statistical analysis 
 Statistical analysis was carried out to see the differences between the experiments with a 
confidence interval of 95% by using analysis of variance (ANOVA). Comparison of means was 
carried out using Tukey’s HSD test. All the experiments are repeated in triplicates (n=3). 
3.3 Results  
3.3.1 Probiotic resistance to SGJ  
To determine the effect of prolonged exposure of probiotics to the acidic pH of the 
stomach, a 2 h in vitro SGJ survival assay was employed (Figure 3.3.1).  
 57 
 
Figure 3.3.1 Survival of L. acidophilus (A), B. adolescentis (B), B. catenulatum (C), and B. 
infantis (D) in SGJ pH 2.0 (●) and pH 6.0 (○). The data are expressed as mean ± one standard 
deviation (n=3) 
 
 
Results from these experiments demonstrated that L. acidophilus ATCC 11975 was the 
most resistant (D-value 10.2 ± 0.8 min) to SGJ (pH 2.0) (Table 3.3.1), but could not survive 
longer than 30 min of exposure under these conditions. The D-value of L. acidophilus was 
significantly (P < 0.05) more than other tested strains. Whereas, the viability of L. acidophilus 
was not significantly affected (P > 0.05) at pH 4.0 and 5.0 and remained viable even after 3 h of 
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exposure to SGJ (Figure 3.3.2). Plate count data revealed that none of the three Bifidobacterium 
spp. tested could survive more than 15 min of exposure to pH 2.0 SGJ, with viable cell numbers 
decreasing to undetectable levels in this period (Table 3.3.1).  
 
Table 3.3.1 D-values (min) of free and encapsulated probiotics exposed to SGJ (pH 2.0). Data 
are expressed as the mean ± one standard deviation (n=3) 
 
Bacteria D-value (min) 
Survival studies 
L. acidophilus* 10.17 ± 0.80a 
B. catenulatum* 1.26 ± 0.02b 
B. infantis* 1.15 ± 0.04b 
B. adolescentis* 1.12 ± 0.03b 
Encapsulation studies 
L. acidophilus (Free) 0-30 min. 10.05 ± 0.19a 
L. acidophilus (Free) 30-120 min. 61.77 ± 4.25b 
L. acidophilus (Encapsulated) 0-30 min. 59.06 ± 4.91a 
L. acidophilus (Encapsulated) 30-120 min. 138.04 ± 8.04b 
 
a,b Means in columns within a category with unlike superscripts differ (P < 0.05). Statistical 
analysis was done separately for free and encapsulated cells. 
*D-values were determined over the first 5 min due to the rapid depletion of viable free cells.   
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Figure 3.3.2 Survival of L. acidophilus in SGJ pH 4.0 (●) and pH 5.0 (○). The data are expressed 
as the mean ± one standard deviation (n=3) 
 
3.3.2 Probiotic resistance to bile 
The effect of Oxgall bile on the viability of the four probiotics is shown in figure 3.3.3; 
all test strains were able to survive for 5 h in MRS media supplemented with 0.3% bile. Optical 
density data showed that slow growth of all test strains occurred over a 24 h period in the 
presence of 0.3% bile-containing MRS (Figure 3.3.4). Following growth in bile-containing 
media, all tested probiotic strains produced unique crystalline structures, whereas no crystalline 
structures were observed when probiotics were added in control (Figure 3.3.5).  
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Figure 3.3.3 Survival of L. acidophilus (A), B. adolescentis (B), B. catenulatum (C), and B. 
infantis (D) in media containing 0.3% (w/v) Oxgall bile (○) and without added bile (●). The data 
are expressed as the mean ± one standard deviation (n=3) 
  
Optical density results (Figure 3.3.4) suggest that slow growth of all test strains occurred 
in the presence of 0.3% bile containing MRS media, as compared to the control (MRS broth 
without added bile). 
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Figure 3.3.4 Growth of probiotics in A) MRS and B) 0.3% (w/v) Oxgall bile containing MRS 
media. The data are expressed as the mean ± one standard deviation (n=3) 
      
      
 
Figure 3.3.5 Light micrographs (magnification 400X NA 0.22) of crystals formed by test 
probiotic strains cultivated in MRS-broth media supplemented with 0.3% (w/v) Oxgall bile for 
24 h incubation at 37ºC under anaerobic conditions. a) L. acidophilus, b) B. adolescentis, c) B. 
catenulatum and d) B. infantis  
 
 
d c 
a b 
25µm 
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3.3.3 Probiotic adherence to Caco-2 cells 
The in vitro adherence of probiotic bacteria to Caco-2 cells was determined, using a 2 h 
assay, to be species-specific (Figure 3.3.6). The initial number of bacterial cells added to each 
well was 5.4  105 cfu/mL. By the assay endpoint, L. acidophilus was shown to adhere to Caco-2 
cells in the highest numbers (4.5  104 cfu/mL or ~10% of the added cells). In contrast, about    
10-fold fewer B. catenulatum cells attached (3.1  103 cfu/mL), and B. adolescentis and              
B. infantis showed relatively poor adhesion with the number of adhering cells at the end of the 
assay being 2.6  101 and 1.5  101 cfu/mL, respectively. The viability of all tested probiotics 
was not effected in 5% CO2-95% air atmosphere significantly (P < 0.05, data not shown). 
 
 
 
Figure 3.3.6 Adhesion of probiotic bacteria to Caco-2 cells. Data are expressed as the mean ± 
one standard deviation (n=3) 
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3.3.4 Probiotic susceptibility to antibiotics 
It was determined that the patterns of antimicrobial susceptibility of the probiotic strains 
were quite variable (Table 3.3.2). L. acidophilus was found to be resistant to ciprofloxacin         
(4 µg/mL), nalidixic acid (32 µg/mL) and sulfisoxazole (256 µg/mL), and showed intermediate 
resistance to cefoxitin (4 µg/mL), amikacin (8 µg/mL), ceftriaxone (8 µg/mL), gentamicin         
(4 µg/mL), trimethoprim/sulphamethoxazole (1/19 µg/mL), and kanamycin (8 µg/mL).              
B. catenulatum was resistant to nalidixic acid (32 µg/mL) and kanamycin (64 µg/mL) and 
intermediately resistant to amikacin (4 µg/mL), ciprofloxacin (0.5 µg/mL), gentamicin               
(8 µg/mL), sulfisoxazole (64 µg/mL), trimethoprim/sulphamethoxazole (0.25/4.75 µg/mL), and 
streptomycin (32 µg/mL).  
 
Table 3.3.2 Antibiotic resistance profiles of the tested probiotic strains 
 
Antibiotic  Conc. range,  
µg/mL 
L. 
acidophilus 
B. 
catenulatum 
B. 
 infantis 
B. 
adolescentis 
Cefoxitin   32-0.5 I (4.0) S S S 
Amikacin  64-0.5 I (8.0) I (4.0) I (4.0) S 
Chloramphenicol  32-2 S S S S 
Tetracycline 32-4 S S S S 
Ceftriaxone 64-0.25 I (8.0) S I (0.25) S 
Amoxillin/Clavulanic-Acid 32/16-1/0.5 S S S S 
Ciprofloxacin 4-0.015 R I (0.5) I (0.25) S 
Gentamicin  16-0.25 I (4.0) I (8.0) I (2.0) S 
Nalidixic acid  32-0.5 R R R I (0.5) 
Ceftiofur  8-0.12 S S S S 
Sulfisoxazole  256-16 R I (64.0) I (16.0) S 
Trimethoprim/Sulphamethoxazole 4/76-0.12/2.38 I (1.0/19.0) I (0.25/4.75) I 0.25/4.75) S 
Kanamycin  64-8 I (8.0) R I (8.0) R 
Ampicillin 32-1 S S S S 
Streptomycin  64-32 S I (32.0) R S 
 
I, Intermediate (conc. µg/mL); S, Sensitive (No growth in any of the tested conc. range); R, Resistant 
(Growth in highest tested conc.)  
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B. infantis was resistant to streptomycin (64 µg/mL) and nalidixic acid (32 µg/mL) and 
showed intermediate resistance to amikacin (4 µg/mL), ceftriaxone (0.25 µg/mL), ciprofloxacin 
(0.25 µg/mL), gentamicin (2 µg/mL), trimethoprim/sulphamethoxazole (0.25/4.75 µg/mL), and 
kanamycin (8 µg/mL). Lastly, B. adolescentis was resistant to kanamycin (64 µg/mL) and 
showed intermediate resistance to nalidixic acid (0.5 µg/mL). None of the tested probiotics were 
resistant to chloramphenicol, tetracycline, amoxillin/clavulanic-acid, ceftiofur and ampicillin.  
3.3.5 Carbon source utilization of probiotics 
Growth of probiotics on different carbohydrates was tested by adding different 
carbohydrates in basal media (Figure 3.3.7). Carbon source utilization profiles of L. acidophilus, 
B. catenulatum, B. infantis and B. adolescentis are shown in Table 3.3.3, respectively.  
All probiotics were able to utilize glucose (control) and lactose as sole carbon sources. 
Xylose was utilized by B. adolescentis and B. catenulatum. Cellobiose was utilized by               
B. catenulatum and L. acidophilus, where poor growth was observed by the later strain. Slow 
growth of B. adolescentis and B. infantis was observed with methyl-D-glucoside, with a longer 
lag phase (~ 20 h). Analysis of Ecoplate results indicated that all strains grew to the highest 
culture optical densities on D-xylose. B. catenulatum utilized a number of carbohydrates 
including -methyl-D-glucoside, D-cellobiose, and -D-lactose. 
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Table 3.3.3 Optical densities at 590 nm attained after 48 h by probiotics during growth on 
different sole carbon sources. The data are expressed as the mean ± one standard deviation (n=3) 
 
Carbon name B. infantis 
L. 
acidophilus 
B. 
adolescentis 
B. 
catenulatum 
2-hydroxybenzoic acid 0.38 ± 0.03a 0.34 ± 0.03ab 0.29 ± 0.00b 0.38 ± 0.00b 
4-hydroxybenzoic acid 0.38 ± 0.02a 0.34 ± 0.02ab 0.27 ± 0.04b 0.39 ± 0.03b 
D, L-α-glycerol phosphate 0.28 ± 0.01a 0.30 ± 0.09a 0.28 ± 0.00a 0.37 ± 0.02a 
D-cellobiose 0.32 ± 0.04a 0.37 ± 0.07a 0.35 ± 0.02a 0.69 ± 0.04b 
D-galactonic acid γ-lactone 0.31 ± 0.04a 0.38 ± 0.00b 0.27 ± 0.03a 0.37 ± 0.02b 
D-galacturonic acid 0.34 ± 0.04a 0.40 ± 0.03ab 0.31 ± 0.01b 0.40 ± 0.02b 
D-glucosaminic acid 0.30 ± 0.02a 0.37 ± 0.02ab 0.28 ± 0.07ab 0.40 ± 0.01b 
D-malic acid 0.38 ± 0.14a 0.37 ± 0.02a 0.33 ± 0.04a 0.37 ± 0.01a 
D-mannitol 0.38 ± 0.04a 0.36 ± 0.05a 0.32 ± 0.01a 0.40 ± 0.02a 
D-xylose 1.28 ± 0.16a 0.92 ± 0.02a 0.98 ± 0.10ab 1.21 ± 0.12b 
Glucose-1-phosphate 0.37 ± 0.06a 0.34 ± 0.03a 0.31 ± 0.02a 0.39 ± 0.02a 
Glycogen 0.32 ± 0.02a 0.34 ± 0.02ab 0.31 ± 0.02ab 0.37 ± 0.03b 
Glycyl-L-glutamic acid 0.33 ± 0.00a 0.37 ± 0.02b 0.30 ± 0.01c 0.38 ± 0.01c 
i-erythritol 0.38 ± 0.03a 0.40 ± 0.09a 0.28 ± 0.04a 0.39 ± 0.01a 
Itaconic acid 0.35 ± 0.03a 0.38 ± 0.04ab 0.30 ± 0.04ab 0.39 ± 0.00b 
L-arginine 0.32 ± 0.07a 0.39 ± 0.02a 0.28 ± 0.02a 0.35 ± 0.03a 
L-asparagine 0.32 ± 0.03a 0.36 ± 0.04ab 0.29 ± 0.01bc 0.40 ± 0.02c 
L-phenylalanine 0.46 ± 0.04a 0.37 ± 0.05ab 0.34 ± 0.01bc 0.47 ± 0.04c 
L-serine 0.40 ± 0.01a 0.38 ± 0.06ab 0.29 ± 0.05ab 0.39 ± 0.00b 
L-threonine 0.36 ± 0.03a 0.38 ± 0.05a 0.33 ± 0.05a 0.41 ± 0.01a 
N-acetyl-d-glucosamine 0.38 ± 0.03a 0.52 ± 0.06a 0.30 ± 0.02ab 0.41 ± 0.05b 
Phenylethlamine 0.35 ± 0.01a 0.34 ± 0.01b 0.29 ± 0.01bc 0.37 ± 0.01c 
Putrescine 0.35 ± 0.08a 0.34 ± 0.02a 0.29 ± 0.02a 0.31 ± 0.10a 
Pyruvic acid methyl ester 0.30 ± 0.01a 0.47 ± 0.03ab 0.22 ± 0.09bc 0.36 ± 0.01c 
Tween 40 0.32 ± 0.06a 0.27 ± 0.09a 0.28 ± 0.06a 0.37 ± 0.17a 
Tween 80 0.27 ± 0.07a 0.29 ± 0.10a 0.28 ± 0.05a 0.45 ± 0.09a 
water 0.30 ± 0.03a 0.35 ± 0.03a 0.27 ± 0.03a 0.32 ± 0.09a 
α-cyclodextrin 0.32 ± 0.04a 0.34 ± 0.02ab 0.29 ± 0.01ab 0.38 ± 0.05b 
α-D-lactose 0.37 ± 0.13a 0.40 ± 0.07a 0.44 ± 0.01a 0.97 ± 0.07b 
α-Ketobutyric acid 0.36 ± 0.01a 0.39 ± 0.05a 0.29 ± 0.05a 0.37 ± 0.03a 
β-methyl-D-glucoside 0.33 ± 0.04a 0.47 ± 0.03b 0.37 ± 0.08ab 0.82 ± 0.01c 
γ-hydroxybutyric acid 0.44 ± 0.02a 0.42 ± 0.08a 0.35 ± 0.00a 0.44 ± 0.03a 
a,b,c  Means in a row within a category with unlike superscripts differ (P < 0.05). 
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Figure 3.3.7 Maximum optical densities (O.D. 600) attained by probiotics during growth on 
different carbon sources. Data are expressed as the mean ± one standard deviation (n=2) 
 
3.3.6 Survival of encapsulated L. acidophilus in SGJ  
L. acidophilus was selected for encapsulation and subsequent challenge, in vitro, to 
simulated gastric conditions (pH 2.0). The PPI-AL microcapsules, prepared by extrusion, were 
teardrop in shape and uniform in size (~3 mm) (Figure 3.3.8). The survival of L. acidophilus in 
acidic condition is shown in Figure 3.3.9, and clearly demonstrates a protective effect of 
encapsulation during the 2 h exposure to simulated gastric conditions with only a ~1 log cfu/mL 
loss in cell viability. Whereas, unprotected L. acidophilus cells underwent a >6 log cfu/mL loss 
in cell viability over the same period (P < 0.05). Comparing D-values of the encapsulated and 
un-encapsulated cells (Table 3.3.1) revealed that the PPI-AL matrix improved survival by almost 
6 times (59.0 ± 5.0 min versus 10.1 ± 0.2 min; D-value for the free cells calculated over the first 
30 min). 
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Figure 3.3.8 Light micrograph of pea protein-alginate beads prepared by extrusion  
 
Viability of L. acidophilus cells remained relatively unchanged for both free and 
encapsulated cells for a period of 2 h incubation at pH 6.0.  
 
Figure 3.3.9 Survival of free (solid symbols) and encapsulated (open symbols) L. acidophilus in 
SGJ of pH 2.0 (●, ○) and pH 6.0 (▼, Δ). The data are expressed as the mean ± one standard 
deviation (n=3) 
   10 mm 
10mm 
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3.4 Discussion 
The human GIT is a complex microbial community consisting of ~1010-1014 cfu of 
bacteria per gram of faecal material. Given such high numbers and diversity, it is not surprising 
that the composition and numbers of these organisms should play a significant role in human 
health and disease. Within this community, probiotics (lactobacilli and bifidobacteria) have been 
studied for their health promoting and otherwise beneficial effects (Dunne et al., 2001; Goktepe 
et al., 2006). However, for probiotics to exert beneficial effects in the GI tract, they must survive 
transit through the stomach. Each day, the human stomach secretes about 3 L of gastric juice 
with a pH of around 2.0. The transit time of food in the stomach is between 2 and 4 h (Smith, 
1995); liquids take about 20 min to pass through the stomach (GastroNet Australia, 2001). 
Hence, it is necessary for probiotic microorganisms, if unaided or unprotected, to tolerate the 
acidic conditions of the stomach for periods of up to 4 hrs so that they may reach the colon in a 
viable state. Lactobacilli of intestinal origin are considered intrinsically-resistant to acidic 
environments and are often employed in fermented foods as probiotics. In order to improve the 
numbers of surviving probiotics during gastric transit, components such as milk (Conway et al., 
1987), milk proteins (Charteris et al., 1998a), cheese and yogurt (Gardiner et al., 1999), 
reconstituted skim milk with gum acacia (Desmond et al., 2002), and cereal extracts have been 
used (Charalampopoulos et al., 2003). However, actual in vivo data demonstrating this enhanced 
survival is lacking. Figure 3.3.1 shows that simulated gastric conditions with a pH of 2.0 were 
lethal in as little as 10 min for all unprotected probiotics tested, with the exception of                 
L. acidophilus which survived for 30 min. Thus, L. acidophilus was most likely to survive 
passage through the stomach compared with the other probiotics tested in this study. For 
Bifidobacteria spp., transit through the stomach gastric conditions would only be possible if the 
pH was raised to above 4.0 if, for example, the organism was ingested along with a meal. 
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Raising the pH to 4.0 or 5.0 also significantly improved the survival kinetics of L. acidophilus 
strains (Figure 3.3.2); this would likely be a viable strategy for improving survival of probiotics 
through the stomach environment. 
Bile tolerance by probiotics has been shown to be strain- and bile type-dependent, with 
resistance levels ranging from bile concentrations of 0.125 to 2.0% (Lian et al., 2003; Margolles 
et al., 2003). While all strains involved in this study could tolerant 0.3% Oxgall bile (Figure 
3.3.3), there were some minor differences.  In general, the required concentration of bile salts 
considered necessary to screen for resistant strains for human use is 0.3%.  
 In the current study, crystalline floccules were found in broth media containing bile (Figure 
3.3.4) and were species specific. Zavaglia et al. (2002) suggested that when cultures are exposed 
to bile, changes take place in the cell membrane causing auto-aggregation and subsequently, 
flocculation. Metabolic actions of the live cells or the work of enzymes released from lysed dead 
cells in the culture medium could induce a chemical reaction which makes the bile component of 
the medium insoluble. The significance of the different shapes of crystals formed by the tested 
probiotic panel in current study is not yet clear and to my knowledge has not previously been 
described. 
The adhesion of probiotic strains to intestinal epithelial cells is considered as a 
prerequisite feature for attachment and proliferation in the intestinal environment (Kailasapathy 
and Chin, 2000). Adhesion has also been cited as important for transient colonization (Alander et 
al., 1999), enhanced healing of the damaged gastric mucosa (Elliott et al., 1998), modulation of 
the immune system (Perdigon et al., 2002) and antagonism against pathogens (Jin et al., 2000).  
Caco-2 cell lines have seen extensive use as an in vitro model of the human intestinal epithelium 
for screening probiotic adherence (Gopal et al., 2001), and culture plating has been employed to 
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count the total adhering bacteria to Caco-2 cells (Forestier et al., 2001; Matijasic et al., 2003; 
Bertazzoni-Minelli et al., 2004; Pennacchia et al., 2006). Previously, the adhesion of L. casei 
rhamnosus Lcr35 was studied using an initial bacterial inoculum of 109 cfu/well, where the final 
number of viable adhering bacterial cells was a little less than 105 cfu/well (Forestier et al., 
2001). In a second study, adhesion percentages of six L. casei strains were calculated, in which 
four had an adhesion percentage ranging from 0.3 to 0.74 (Bertazzoni-Minelli et al., 2004). Two 
L. gasseri strains of human origin, K7 and LF221 showed good adhesion with Caco-2 cells, 
when added with an initial concentration of 109 cfu/well, yielding final numbers of viable 
adhering bacterial cells of 107 cfu/well (Matijasic et al., 2003). Finally, the eight Lactobacillus 
strains belonging to the L. plantarum-group were analysed by Pennacchia et al. (2006). The 
number of final adhering bacteria was ~107 cfu/mL when 109 cfu/well was added initially. In the 
present study, the probiotic strains examined were shown to attach to the Caco-2 cells in vitro 
with varying success, as shown in figure 3.3.6. Clearly, L. acidophilus showed higher or similar 
adhesion levels to those results described above (Forestier et al., 2001; Matijasic et al., 2003; 
Bertazzoni-Minelli et al., 2004; Pennacchia et al., 2006). Among the Bifidobacterium strains 
tested B. catenulatum attached considerably more strongly to Caco-2 cells in comparison with   
B. adolescentis and B. infantis, suggesting the latter strains may have limited use as probiotics 
when viewed from the adhesion perspective.  
It has also been reported that some lactobacillus strains can strongly adhere to the gut 
mucosa, where they subsequently interfere with the adhesion of pathogenic bacteria to intestinal 
cells (Servin, 2004). Adherence to the intestinal epithelial cells is also an important requirement 
for colonization by micro-organisms, and for bacterial pathogens, which is a pivotal step for 
virulence (Westerlund and Korhonen, 1993). The ability of some lactobacillus strains to           
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co-aggregate with intestinal pathogens in intestinal lumen might prevent pathogens from 
reaching the intestinal mucosa. At the same time, production of antimicrobial compounds by 
probiotics helps to kill enteric pathogens and ultimately reduce their population in the GIT. As 
adhesion to intestinal tissue has been considered to be one of the cornerstones of probiotic 
function, it was considered in the present work as one of the main criteria for probiotic selection 
for encapsulation; thus, L. acidophilus, which attached at a rate of ~10% of the cells used in the 
assay, was the most successful probiotic of the tested panel. However, there is a lack data 
indicating that probiotic gut colonization occurs, or that it is even necessary for a probiotic effect 
to be realized (Tappenden and Deutsch, 2007).  
There is limited information on the resistance of probiotic bacteria to antimicrobials of 
clinical importance and even a more limited understanding of how these resistance factors 
influence probiotic reproductive success. Antibiotic resistance of probiotics might be a desirable 
feature, as it could potentially aid in their survival in the GIT, especially when used after 
antibiotic therapy or in co-administration with antibiotics to restore intestinal health (Salminen et 
al., 1998a). Alternatively, resistance to these agents could increase the spread of resistance 
within the dense, diverse anaerobic microbial population (including pathogens) inhabiting the 
GIT of humans and animals (Scott, 2002). The antibiotic susceptibility system used in this study 
is a microtiter plate-based version of the classic broth dilution method for testing for antibiotic 
susceptibility, and provided both qualitative and quantitative susceptibility results. All tested 
probiotics were resistant to Gram-negative spectrum-antibiotic nalidixic acid (conc. 32 g/mL), 
whereas, B. adolescentis showed intermediate resistance (Table 3.3.2). Charteris et al. (1998b) 
reported resistance of B. adolescentis and B. infantis to nalidixic acid (30 µg/mL). Kanamycin 
resistance (30 µg/disk) and sensitivity to the broad-spectrum antibiotics chloramphenicol         
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(32 µg/disk) and tetracycline (30 µg/disk) of tested Lactobacilli and Bifidobacteria strains were 
reported by Zhou et al. (2005). Similarly, all probiotics tested in the present study were sensitive 
to chloramphenicol (32 µg/mL) and tetracycline (32 µg/mL), B. catenulatum and B. adolescentis 
were resistant to kanamycin conc. 64 g/mL, whereas, L. acidophilus and B. infantis showed 
intermediate resistance to kanamycin. L. acidophilus, B. catenulatum and B. infantis showed 
intermediate resistance to the combination of trimethoprim/sulphamethoxazole. Studies by 
Masco et al. (2006) showed reduced resistance of bifidobacteria against a therapeutic 
combination of trimethoprim and sulphamethoxazole due to their synergistic inhibitory effect on 
thymidine synthesis.  
 At any given time, the human colon and particularly the proximal bowel contain many 
different types of carbohydrates. Consequently, bacteria which can adapt rapidly to the changing 
substrate availability and grow on a variety of carbon sources will have a competitive advantage 
in the GIT ecosystem (Macfarlane et al., 2008). Carbon substrate utilization was highly variable 
among tested probiotics and considerable inter-species and inter-strain differences existed, as 
shown in Table 3.3.3. While individual probiotic species exhibited unique carbohydrate substrate 
preferences, several trends in carbon source utilization emerged from this study. For example, 
the highest culture optical densities were recorded by B. catenulatum (Table 3.3.3) for a number 
of carbohydrates, including -methyl-D-glucoside, D-cellobiose, D-xylose and -D-lactose. 
Similarly, rapid growth of B. catenulatum was observed in the presence of lactose and xylose 
(Hopkins et al. 1998). Fermentation of cellobiose by B. catenulatum strains was previously 
reported by Salminen et al. (1998a); whereas, B. adolescentis and B. infantis did not ferment 
cellobiose (Roy and Ward, 1990). Low utilization of Tween-40 and Tween-80 were recorded for 
L. acidophilus and B. infantis. Similarly, maximum specific growth rates of 0.25 and 0.29 were 
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recorded by B. catenulatum and B. adolescentis strains with xylose; whereas, B. infantis did not 
show appreciable growth in the presence of xylose (Hopkins et al., 1998). In the present study, 
the highest optical densities for all the probiotics tested were observed when D-xylose was 
provided as the sole carbons source. The differences in carbon source utilization patterns 
observed in this study may have particular interest from the viewpoint of future prebiotic 
development. Use of such compounds to target specific organisms in the large intestine would be 
of great value for defined health-promoting purposes in future.  
Buffering capacities, carbohydrate and protein constituents, and encapsulation are some 
of the technologies that have been used previously for increasing probiotic survival in acidic 
environments (Corcoran et al., 2005). Encapsulation is currently seeing intense focus as a 
physical means for protecting probiotics from the harsh effects of the gastric environment 
(Mortazavian et al., 2007). Microencapsulation using cellulose acetate phthalate protected 
bifidobacteria quite notably during spray drying and during prolonged exposure to simulated 
gastric conditions (Favaro-Trindale and Grosso, 2002). Emulsification, gelation and film 
formation are some of the properties which supports the technological utilisation of pea proteins 
(Choi and Han 2002; Rangel et al. 2003). Pea protein has also been utilised for 
microencapsulation of α-tocopherol (Pierucci et al., 2007) but to my knowledge has not been 
used for entrapping live microorganisms. Transformation towards strictly plant-based protein 
materials would be advantageous, as probiotics ingredients could be then incorporated into    
non-dairy products, or have greater acceptance in materials that restrict animal-derived materials 
(eg; gelatin, whey). While a number of capsule matrices have been explored, the cross-linked 
alginate matrix system has most frequently seen application for LAB encapsulation (Sheu et al., 
1993). However, these systems appear to be subject to a more rapid degradation and release of 
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active ingredients at low pH (Gombotz and Wee, 1998). Lee and Heo (2000) showed that 
Bifidobacterium longum encapsulated in calcium alginate containing 2.0, 3.0, and 4.0% sodium 
alginate survived exposure to SGJ (pH 1.5) significantly better than free cells. The death rate of 
the cells in the beads decreased proportionally with an increase in both the alginate gel 
concentration and bead size. However, survival of probiotics in alginate starch microcapsules 
was improved during refrigerated storage in yoghurt but not after exposure to acid and bile 
solutions (Sultana et al., 2000). Microencapsulated L. acidophilus strains showed 2-3 log 
improvement in viability after 3h of incubation at pH 2.0, when compared to free cells 
(Chandramouli et al. 2004). Similarly, non-encapsulated cells were completely destroyed when 
exposed to artificial gastric juice of pH 1.2 and 1.5 for 3 h, while the treatment reduced the 
viable count of encapsulated cells only by 3 log units (Kim et al. 2008). In the present study 
(Figure 3.3.9), encapsulation of L. acidophilus within pea protein – alginate capsules resulted in 
an approximate 6-fold increase in the survival of bacteria in pH 2.0 SGJ. 
 
3.5 Connection to the next study 
Preliminary screening of co-aggregation potential may be useful to identify potential probiotic 
strains suitable for food, human or animal use. Co-aggregation of probiotics with pathogens 
could potentially interfere with pathogen colonization of the GIT, survival (through various 
antimicrobial mechanisms) and subsequent manifestation of illness. In addition, co-aggregation 
of probiotics with other established commensal GIT microflora may aid in the attachment and 
colonization of probiotics to mucosal surfaces. Thus, the next study was performed to elucidate 
the aggregation and antibacterial properties of tested probiotic strains.  
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4 In vitro growth control of Escherichia coli O157:H7 and Clostridium sordelli ATCC 
9714 by the probiotic Lactobacillus acidophilus ATCC 11975 
Abstract 
A panel of probiotic strains, including Lactobacillus acidophilus ATCC 11975, 
Bifidobacterium infantis ATCC 15697D, Bifidobacterium catenulatum ATCC 27675 and 
Bifidobacterium adolescentis ATCC 15703, were screened, using the agar spot test for their in 
vitro antibacterial activity against Escherichia coli O157:H7 and Clostridium sordelli ATCC 
9714. Based on preliminary findings, L. acidophilus was then examined in more detail for its in 
vitro co-aggregation and antimicrobial activity against E. coli O157:H7 and Cl. sordelli. Cell 
surface properties of probiotic and pathogen strains were characterized in terms of adhesion to 
hydrocarbons (BATH), and their relative auto- and co-aggregation abilities. Cl. sordelli showed 
the highest 66.0 ± 5.5 % hydrophobicity and was also the most successful auto-aggregating 
strain, showing 63.6 ± 1.4 % auto-aggregation after 24 h incubation at 37°C under anaerobic 
conditions. L. acidophilus was able to co-aggregate with both tested pathogens and showed 47.9 
 3.6 % and 51.8  4.2 % co-aggregation with E. coli and Cl. sordelli, respectively. Bactericidal 
activity of probiotic supernatant (cell-free) was observed, as the number of viable bacteria was 
reduced over 24 h by approximately 4 log and 2 log cfu/mL for E. coli and Cl. sordelli, 
respectively. In general, L. acidophilus-mediated inhibition of E. coli was greater than that of Cl. 
sordelli. Antagonistic activity of the probiotic strain appeared to be partially pH-independent, as 
the use of buffered MRS (containing 0.2% sodium bicarbonate) agar media did not completely 
eliminate the inhibitory activity. Antagonistic activity was shown to be related to heat-stable 
non-proteinaceous compound(s), which were resistant to heating at 100C for 10 min and to 
trypsin (1 mg/mL).  
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4.1 Introduction 
The use of LAB as probiotics for the therapeutic treatment of a broad number of 
gastrointestinal conditions and infectious diseases (e.g., rotavirus diarrhea, influenza virus and 
Helicobacter pylori) has increased over the last few years (Goktepe et al., 2006). Lactobacilli 
and bifidobacteria, the most commonly-cited probiotic genera, reportedly play a significant role 
in maintaining the intestinal microflora and stimulating the immune system of its host (Saarela et 
al., 2002). When present in sufficient numbers (107 cfu/g or mL), probiotics are believed to 
create a healthy equilibrium between beneficial and potentially harmful microflora in the gut 
(Suskovic et al., 2001). Lactobacillus spp., such as L. acidophilus, L. bulgaricus, L. lactis along 
with Bifidobacterium bifidum and Streptococcus faecium constitute an integral part of the healthy 
gastro-intestinal microecology (Fernandes et al., 1987).  
Antimicrobial substances produced by probiotics, either singly or in combination, may 
have bactericidal or bacteriostatic effects on other microbial populations. These antimicrobial 
effects can alter the proliferation of undesired pathogens by influencing the outcome of 
competition for chemicals or available energy (Fredrickson and Stephanopoulos, 1981). 
Production of antibacterial substances such as antibiotics (Shahani et al., 1976), bacteriocins 
(Barefoot and Klaenhammer, 1983; Millette et al., 2007), diacetyl and ammonia (Vandenbergh, 
1993), hydrogen peroxide (Dahiya and Speck, 1967; Reid, 2000) and organic acids such as 
acetic, propionic and lactic acid (Naaber et al., 2004) by certain L. acidophilus strains have been 
reported. The in vitro production of inhibitory compounds toward known pathogens by various 
probiotic species has often been used in the selection of candidate probiotic strains.  
In vitro inhibitory activity against a wide range of bacteria, including Clostridium spp., 
Bacteroides spp., Bifidobacterium spp., Enterobacteriaceae spp., Pseudomonas spp. 
Staphylococcus spp., and Streptococcus spp., has been shown by Lactobacillus spp. strain GG, 
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isolated from the human GI tract (Silva et al., 1987). Lactobacillus gasseri, which is considered 
to be a dominant inhabitant of the human intestine, was found to produce a bacteriocin that 
exhibited a wide spectrum of bactericidal activity against enteric pathogens. Early studies 
explored the use of oral preparations of viable Lactobacillus acidophilus in the treatment of 
functional gastrointestinal disturbances (Rafsky and Rafsky, 1955). Subsequently, Vincent et al. 
(1959) found that L. acidophilus produced lactocidin, a substance with broad antibacterial 
properties. 
Co-aggregation is a process by which genetically-distinct bacteria become attached to 
one another via specific lectin-like adhesins and receptor molecules. Only a limited number of 
studies have examined probiotic-pathogen co-aggregation, on the basis that it might be an 
important protective mechanism against pathogen colonization in the gastrointestinal tract (GIT) 
(Reid et al., 1988; Schellenberg et al., 2006; Collado et al., 2008). Cumulative evidence, 
especially from oral microbiology work, suggests that aggregation influences the development of 
complex multispecies biofilms (Rickard et al., 2003). Bacterial aggregation between 
microorganisms of the same strain (auto-aggregation) or between genetically-divergent strains 
(co-aggregation) is likely of considerable importance in the human GIT, where mechanisms for 
colonizing the epithelial lining, and the organisms that inhabit it, would likely be necessary for 
any subsequent probiotic effect (Collado et al., 2008). A relationship between auto-aggregation 
and adhesion ability has been reported for some bifidobacterial spp., and a correlation between 
adhesion ability and hydrophobicity has been observed in some lactobacilli (Del Re et al., 2000). 
Furthermore, it has been suggested (Collado et al., 2007) that co-aggregation of bacteriocin-
producing LAB with pathogens, may constitute an important host-defence mechanism against 
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infection. Co-aggregation with potential gut pathogens could therefore contribute to the probiotic 
properties ascribed to specific LAB. 
The objective of the present study was to determine cell surface hydrophobicity, auto-
aggregation and pathogen co-aggregation properties of probiotic strain L. acidophilus ATCC 
11975. Antibacterial properties of this probiotic strain were then evaluated against selected 
pathogens.  
4.2 Materials and methods 
4.2.1 Bacteria and culture conditions 
The probiotic strains Lactobacillus acidophilus ATCC 11975, Bifidobacterium infantis 
ATCC 15697D, Bifidobacterium catenulatum ATCC 27675 and Bifidobacterium adolescentis 
ATCC 15703 were purchased from the American Type Culture Collection (ATCC, Manassas, 
VA), and stored at -80°C using 10% glycerol amended in culture broth as a cryoprotectant. 
Lactobacilli De Man Rogosa and Sharpe (MRS) broth (VWR International Ltd., Mississauga, 
ON) was used as a culture media for lactobacilli; whereas, MRS supplemented with 0.05% w/v 
L-cysteine HCl was used for bifidobacteria. Prior to each assay, stock cultures were propagated 
twice in fresh MRS broth and then incubated anaerobically (10% H2, 10% CO2, and 80% N2) at 
37°C for 24 h. Seed culture was harvested at the end of the exponential phase of growth 
(approximately 20 h) by centrifugation at 3,250 × g (Model 5810 R equipped with a swing-
bucket rotor A-4-81; Eppendorf, Hamburg, Germany) for 10 min at 4°C and washed twice with 
phosphate-buffered saline (PBS, 4.3 mM Na2HPO4.7H20, 137 mM NaCl, 2.7 mM KCl, 1.4 mM 
KH2PO4, pH 7.2) and resuspended in peptone saline (PS, 8.5 g/L NaCl, 1.0 g/L peptone, pH 7.0). 
Escherichia coli O157:H7 strain B1 was grown in Luria-Bertani medium (LB, Sigma-Aldrich 
Canada Ltd., Oakville, ON) and incubated aerobically at 37C. Clostridium sordelli ATCC 9714 
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was grown in Reinforced Clostridial Medium (RCM, Oxoid Ltd., Hampshire, UK) and incubated 
anaerobically. All anaerobic culture work was conducted using an anaerobic chamber (Forma 
Scientific, Inc., Model 1025, Marietta, OH) maintained at 37C. 
4.2.2 Detection of antimicrobial activity  
This assay was a modification of the agar spot test described by Jacobsen et al. (1999). 
Test probiotic cultures were spotted (~ 2 µL) on the surface of MRS agar and on MRS agar 
containing 2 g/L NaHO3 (Fisher Scientific Co., Fair Lawn, NJ) to neutralize any acid effect 
(Toure et al., 2003). Plates were incubated anaerobically at 37°C for 24 h to develop the colony 
spots. Anaerobic conditions were used to minimize the formation of hydrogen peroxide and 
acetic acid.  The inhibitory effect of MRS was tested as a negative control on each plate. A 100 
µL volume of an overnight culture of the indicator (pathogen) bacteria was then mixed with        
7 mL of soft agar (0.7% agar), using Luria-Bertani (LB) agar for E. coli O157:H7, and RCM for 
Clostridia spp., and poured over the probiotic spot. The plates were incubated anaerobically (for 
Clostridia spp.) or aerobically (for E. coli O157:H7) at 37ºC for an additional 24 h, after which 
inhibition zones were quantified in centimeters. Each test was performed in triplicate. 
4.2.3 BATH (Bacterial adhesion to hydrocarbons) test 
The bacterial adhesion to hydrocarbons (BATH) test was performed according to the 
method of Collado et al. (2008) with minor modifications. Overnight cultures were harvested by 
centrifugation at 3,250 × g (Model 5810 R with swing-bucket rotor A-4-81; Eppendorf, 
Hamburg, Germany) for 15 min at 4°C and washed once with PBS and resuspended in the same 
buffer, after which the absorbance (A600) of the cell suspension was measured. Equal proportions 
of viable bacterial culture and solvent (xylene) were then mixed by vortexing for 2 min. A 2-
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phase system developed and the aqueous phase was removed for determination of absorbance 
(A600) after 30 min at room temperature. Affinity to hydrocarbons (hydrophobicity) was reported 
as the average percentage of 3 replicates, according to the formula BATH% = [(A0-A)/A0] × 100, 
where A0 and A are the absorbance before and after mixing with xylene, respectively. The effect 
of CaCl2, MgCl2, EDTA and Oxgall bile on cell wall hydrophobicity of probiotics was also 
determined by growing them in MRS media containing CaCl2 (Conc. 0.5, 5.0 and 10.0 mM), 
MgCl2 (Conc. 0.5, 5.0 and 10.0 mM), EDTA (0.1, 0.3 and 0.5 mM) and Oxgall bile (0.1, 0.3 and 
0.5 mM) overnight. 
4.2.4 Auto-aggregation analysis 
Aggregation of the bacterial cultures was screened using spectrophotometric assays, as 
described by Collado et al., (2008). Overnight cultures were centrifuged and washed twice with 
PBS buffer and suspended in the same buffer. Equal volumes of each of the microbial 
suspensions were combined in sterile test tubes and mixed for 10s on a vortex mixer, and then 
incubated at 37ºC for 24 h without agitation, anaerobically. The percent aggregation was 
calculated using the formula 1 – (ATime /Ainitial) × 100, where ATime represents the absorbance of 
the culture after incubation.  
4.2.5 Co-aggregation analysis 
The co-aggregation test was performed using bacterial suspensions prepared as described 
for the auto-aggregation analysis, as follows. Absorbance (A600) of upper suspension was 
measured after 0, 2, 4, and 24 h of incubation. The co-aggregation (%) was calculated according 
to the following equation:  [(Apat + Aprobio) - (Amix)/(Apat + Aprobio)] × 100, where, Apat and Aprobio 
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represent A600 of the pathogen (pat) and probiotics (probio) suspensions at time 0 min and Amix 
represents A600 of the mixed bacterial suspension at different times. 
Aggregation (auto- and co-aggregation) abilities of micro-organisms were screened by 
visual observation, and the degree of aggregation was recorded on a scale 0 to 4+ as follows: a 
score of 0 for no visible aggregates in the cell suspension, 1+ for small uniform aggregates in the 
suspension, 2+ for aggregates that were easily seen but did not settle, 3+ for large aggregates 
which settled and left some turbidity in the supernatant fluid, and 4+ for large aggregates which 
settled and left clear supernatant fluid. Co-aggregation was considered to occur when the score in 
the reaction mixtures was greater than the auto-aggregation score of either strain in monoculture. 
Unstained co-aggregates were also observed under microscope using a 10X dark-field 
objective lens (0.22 numerical aperture, Carl Zeiss MicroImaging GmbH, Jena, Germany).  
4.2.6 Detection of antimicrobial activity of the probiotic supernatant  
Extracellular inhibitory substances produced by L. acidophilus and present in the culture 
medium were studied by a modified agar well-diffusion technique (Toure et al., 2003). An 
overnight MRS culture of L. acidophilus grown under standard conditions (section 4.2.1) was 
centrifuged at 10,000 × g (Sorvall superspeed RC2-B) for 30 min at 4°C and the supernatant was 
collected. Supernatant was tested for heat stability (100°C for 10 min), and sensitivity to trypsin 
(EC 3.4.21.4; Sigma Chemical Co., St. Louis, MO) at a final concentration of 1 mg/ml (pH 8.0) 
at 37°C for 1 h. A 7 mL aliquot of LB or RCM soft agar (0.7% agar) was seeded with 100 µL 
volume of an overnight culture of the pathogen indicator strain at a final concentration of ~107 
cfu/mL, and poured on the top of LB or RCM agar plates and allowed to solidify at room 
temperature. Wells (7 mm) aseptically cut in the solidified agar were filled with either 80 L of 
treated or untreated supernatant. The plates were left at 5°C for 2 h to allow diffusion of the 
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tested supernatant and then incubated aerobically (for E. coli O157:H7) or anaerobically (for Cl. 
sordelli) for 24 h at 37°C, after which zones of inhibition were measured. 
4.2.7 Growth inhibition assay 
Growth inhibition of pathogens by the supernatant of the probiotic was tested using the 
assay described by Forestier et al. (2001). Briefly, overnight L. acidophilus cultures were 
pelleted at 10,000 × g (Sorvall superspeed RC2-B) for 30 min at 4°C, and the supernatant fluid 
collected and filtered using a 0.2 µm pore size syringe filter (Fisher Scientific Co., Fair Lawn, 
NJ) to remove any remaining bacteria. Pathogenic strains to be tested were cultured overnight in 
their respective media (section 4.2.1). Pathogenic bacteria were harvested by centrifuging at 
3,250 × g (Model 5810 R with swing-bucket rotor A-4-81; Eppendorf, Hamburg, Germany) for 
10 min at 4°C. The supernatant was discarded and the cells were washed once and resuspended 
using PBS. The growth inhibition assay was performed by incubating an equal volume of the 
pathogen culture (containing approximately 1.1  108 cfu/mL) along with the probiotic 
supernatant at 37°C for 24 h. Experiments with Cl. sordelli were conducted under anaerobic 
conditions. MRS broth (pH 6.8 ± 0.2) was used as a control. For both pathogens, aliquots were 
removed after every 2 h and serially diluted and plated on the appropriate media to quantify the 
number of surviving bacterial. Control experiments were performed by incubating the same 
number of pathogens with MRS broth instead of probiotic supernatant. All experiments were 
conducted in triplicate. 
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4.3 Results  
4.3.1 Agar-spot test 
Strong antagonistic activity against the tested pathogen strains was detected by the 
probiotic strains using the agar-spot method (Figure 4.3.1). All probiotics tested demonstrated 
inhibition against the enteric pathogens tested. However, L. acidophilus showed the most 
effective inhibition of E. coli O157 and Cl. sordelli with a zone diameter of 0.8 ± 0.3 cm and 1.4 
± 0.2 cm (Table 4.3.1), respectively, and was selected for further tests to determine its cell 
surface hydrophobicity, auto-aggregation, co-aggregation and antimicrobial activity with tested 
pathogen strains. 
 
                          
 
Figure 4.3.1 Antimicrobial activities of probiotics against E. coli O157. Agar spot test showing 
zone of inhibition around probiotic spot. Spots represent: A) B. infantis; B) B. adolescentis; C) 
L. acidophilus; and D) B. catenulatum  
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Table 4.3.1 Inhibition of selected pathogenic bacteria by probiotics as determined by agar spot 
test 
 
Probiotics  
Pathogens B. infantis B. adolescentis L. acidophilus B. catenulatum 
E. coli O157a 0.7 ± 0.2 0.6 ± 0.2 0.8 ± 0.3 0.4 ±  0.2 
Cl. sordellia 0.4 ± 0.2 0.5 ± 0.1 1.4 ± 0.2 1.0 ± 0.3 
a Zones of inhibition are expressed as the diameter in cm. The data are expressed as mean ± one 
standard deviation (n=3). 
 
 
The diameter of zones of inhibition of L. acidophilus was found to be reduced by 
approximately 50% when 0.2% sodium-bicarbonate (acid control) was added to the MRS agar 
media (Table 4.3.2 and Figure 4.3.2). The control treatment (MRS media alone) showed no 
inhibitory effect against the pathogens tested (data not shown).  
 
Table 4.3.2 Antibacterial activities of L. acidophilus against selected pathogenic bacteria 
 
Pathogens Diameter of zones (cm) on MRS 
Diameter of zones (cm) on MRS (0.2% Na-
carbonate) 
 
E. coli O157a 0.8  0.3 0.5 ± 0.2 
Cl. sordellia 1.4 ± 0.2 0.7 ± 0.1 
aThe data are expressed as mean ± one standard deviation (n=3). 
 
 
 
 85 
                         
 
Figure 4.3.2 Agar-spot test showing antibacterial activity of L. acidophilus on MRS agar medium 
overlaid with Luria-Bertani (LB) soft agar seeded with E. coli O157:H7. A) MRS (control), and 
B) MRS containing 0.2% (w/v) sodium-bicarbonate  
 
4.3.2 Bacterial adhesion to hydrocarbons  
The percentage of cells adhering to the hydrocarbon xylene was used to provide an index 
of cell surface hydrophobicity. Percent adhesions of probiotic and pathogen strains to xylene are 
shown in Table 4.3.3. The most hydrophobic tested pathogen strains were Aeromonas hydrophila 
ATCC 7965, Citrobacter freundii ATCC 8090, Clostridium sordelli ATCC 9714, Listeria 
monocytogenes ATCC 43256, Salmonella enteridis ATCC 4931 and Yersinia enterocolitica 
ATCC 35669. The most hydrophobic probiotic strains were Lactobacillus acidophilus ATCC 
11975, Escherichia coli ATCC 14763, Escherichia coli ATCC 4351, Lactobacillus lactis ATCC 
11954, and Bifidobacterium catenulatum ATCC 27675 and Saccharomyces cerevisiae ATCC 
24859. In general, LAB strains showed a lower hydrophobicity than pathogens. Based on 
preliminary findings (Table 4.3.1), L. acidophilus was further studied for its auto- and co-
aggregation properties with E. coli O157:H7 and Cl. sordelli. 
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Table 4.3.3 Percent adhesion to hydrocarbons of enteric pathogens and probiotic strains 
 
Pathogen strains % BATHa 
Aeromonas hydrophilia ATCC 7965 82.0 ± 8.5 
Citrobacter freundii ATCC 8090  61.0 ± 2.3 
Clostridium perfringens ATCC 13124  41.0 ± 4.9 
Cl. sordelli ATCC 9714  66.0 ± 5.5 
Enterobacter aerogenes ATCC 13048  30.0 ± 9.1 
E. cloacae ATCC 13047  0.0 ± 10.0 
Escherichia coli O157:H7  44.5 ± 3.6 
Listeria monocytogenes ATCC 43256 96.5 ± 9.1 
Salmonella enteridis ATCC 4931 69.0 ± 1.4 
Vibrio parahemolyticus ATCC 17802 21.0 ± 12.3 
Yeresinia enterocolitica ATCC 35669 84.0 ± 5.6 
Yeresinia enterocolitica ATCC 9610 17.0 ± 7.2 
Candida albicans ATCC 18804 16.0 ± 8.7 
Probiotic strains  
Saccharomyces cerevisiae ATCC 24859 66.0 ± 3.4 
L. acidophilus ATCC 11975 46.5 ± 6.1 
B.  infantis ATCC 15697 2.5 ± 3.6 
B. catenulatum ATCC 27675 65.5 ± 6.4 
B. adolescentis ATCC 15703 4.0 ± 6.0 
Alcaligenes fecalis DSM 30030 -0.07 ± 0.8 
Enterococcus fecalis ATCC 19433 18.5 ± 1.4 
Enterococcus faecium ATCC 19434 1.0 ± 2.2 
Escherichia coli ATCC 14763 55.0 ± 4.7 
Escherichia coli ATCC 4351 70.0 ± 7.0 
Lactobacillus lactis ATCC 11954 85.0 ± 6.4 
Lactobacillus planetarum ATCC 14917 0.0 ± 3.9 
Lactobacillus rhamnosus ATCC 7469 -16.6 ± 4.3 
aThe data are expressed as mean ± one standard deviation (n=3). 
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4.3.3 Bacterial auto-aggregation and co-aggregation analysis 
The auto-aggregation properties of L. acidophilus and pathogen strains were measured 
over 24 h at 37°C using absorbance measurements at 600 nm. Results of percentage auto-
aggregation are shown in Table 4.3.4. In general, the auto-aggregation abilities of all tested 
strains increased over a period of 24 h incubation at 37°C. Clostridium sordelli was the best 
auto-aggregating strain among those tested, resulting in 63.6 ± 1.4% auto-aggregation after 24 h 
incubation.  
Table 4.3.4 Adhesion to hydrocarbons as measured using the BATH test and % auto-aggregation 
of probiotic and pathogenic strains 
 
% Auto-aggregationa Bacterial strains 
2h 4h 24h 
L. acidophilus ATCC 11975 7.3 ± 1.0 16.9 ± 2.1 36.7 ± 4.5 
E. coli O157:H7 5.2 ± 0.8 15.0 ± 1.0 45.3 ± 7.0 
Cl. sordelli ATCC 9714 15.0 ± 6.3 34.0 ± 5.2  63.6 ± 1.4 
aMean ± standard deviation of results from three separate experiments. 
  
These results were confirmed by visual aggregation determination; a score of 3+ was 
given to Cl. sordelli and L. acidophilus and 2+ was given to E. coli auto-aggregates. 
Lactobacillus acidophilus was able to co-aggregate with both tested pathogens, the results of 
which are shown in Table 4.3.5. 
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Table 4.3.5 Co-aggregation percentages of pathogen and probiotic strains after incubation at     
37ºC, anaerobically 
 
              % Co-aggregation Co-aggregation with L. acidophilus 
2h                                                 4h 24h 
E. coli O157:H7a 16.0  2.4 43.6  1.1 47.9  3.6 
Cl. sordelli ATCC 9714a 23.2  3.2 43.7  1.5 51.8  4.2 
aMean ± standard deviation of results from three separate experiments. 
 
Percent co-aggregation tended to increase over the 24 h incubation period. The percent of 
co-aggregation of L. acidophilus with E. coli O157:H7 was 43.6  1.1% after 4 h incubation and 
47.9  3.6 % after 24 h. Whereas, Cl. sordelli showed 43.7  1.5% co-aggregation after 4 h and 
51.8  4.2% after 24 h incubation at 37°C. These results were also confirmed by visual 
determination (Figure 4.3.3) and microscopic examination (Figure 4.3.4) of co-aggregates. A 
visual score of 3+ was given to both E. coli O157:H7- and Cl. sordelli-L. acidophilus               
co-aggregates. 
 
 
Figure 4.3.3 Visual determination of co-aggregation of L. acidophilus ATCC 11975 with E. coli 
O157:H7. Tubes 1 and 2 represents co-aggregation before (0 h), and after (24 h) incubation, 
respectively 
 
 
1 2 
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Figure 4.3.4 Dark-field (10X NA 0.22) photomicrographs, showing co-aggregates of                  
L. acidophilus and E. coli O157. A) Before incubation, and B) Co-aggregates after incubation at    
37ºC for 24 h   
 
  
4.3.4 Detection of antimicrobial activity of probiotic supernatant 
Antagonistic activity of L. acidophilus supernatant was further evaluated by an agar-well 
diffusion method. No zones of inhibition were observed with cell-free probiotic supernatant. The 
antibacterial activity of probiotic cell-free supernatant (pH 4.5 ± 0.1) was examined in broth 
culture using the Gram-negative aerobe, E. coli O157:H7, and then Gram-positive anaerobic 
pathogen, Cl. sordelli. MRS broth (pH 6.7 ± 0.3) was used as control. Standard plate counts were 
used to determine the viability of the two pathogen strains over a 24 h period (Figure 4.3.5).  
A B 
    100 µm     100 µm 
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Figure 4.3.5 Antimicrobial activity of L. acidophilus supernatant on the growth of A) E. coli and, 
B) Cl.  sordelli 
 
Results showed that pathogen growth was inhibited, and that none of the pathogen strains 
grew in the presence of cell-free probiotic supernatant over the first 10 h. After 24 h incubation, 
the number of viable bacteria was reduced approximately by 4 log and 2 log cfu/ml for E. coli 
O157:H7 and Cl. sordelli, respectively, compared to the pH 6.7 ± 0.3 MRS control (no probiotic 
supernatant; Figure 4.3.5). The treatment of supernatant by trypsin at final concentration of 
1mg/ml and heat (100º C for 10 min) did not affect the inhibitory activity (data not shown). 
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4.4 Discussion 
Cell surface hydrophobicity assays do not measure the intrinsic microbial cell surface 
hydrophobicity, but rather the bacterial partitioning to a certain hydrophobic substrate (i.e., 
xylene). The BATH test has been extensively used for measuring cell surface hydrophobicity in 
LAB (Vinderola et al. 2004; Collado et al. 2008). Many studies showed that the presence of 
(glycol-) proteinaceous material at the cell surface resulted in higher hydrophobicity; whereas, 
hydrophilic surfaces were associated with the presence of polysaccharides (Rojas et al. 1996). In 
the present study, the cell surface hydrophobicity and percent auto-aggregation of common 
enteric pathogens like Salmonella enteridis and Escherichia coli O157:H7, commensal 
microflora of GIT including Escherichia coli ATCC 14763, Escherichia coli ATCC 4351, 
Enterococcus fecalis ATCC 19433, Enterococcus faecium ATCC 19434, and tested probiotics 
were determined and are shown in figure A.1 and A.3 (Appendix A). The effect of different 
cations including MgCl2, CaCl2, EDTA and Oxgall bile on cell surface hydrophobicity of 
probiotics is evaluated (Figure A.2, Appendix A). Cell surface hydrophobicity was found to be 
related to auto-aggregation properties as most of the strains with higher adhesion to 
hydrocarbons showed high auto-aggregation abilities.  
Aggregation properties of probiotics with pathogens may be of importance for both food 
preservation and therapeutic impact on intestinal microbiota. Preliminary screening of              
co-aggregation potential may be useful to identify potential probiotic strains suitable for food, 
human or animal use. The present study was in agreement with the findings of Collado et al. 
(2008) which showed that bacterial strains with higher adhesion to hydrocarbon (xylene) showed 
high auto-aggregation abilities (Table 4.3.4; Figure A.1 and A.3, Appendix A). In vitro analysis 
of the probiotic L. acidophilus demonstrated co-aggregation with both Gram-negative E. coli 
O157:H7 and Gram-positive Cl. sordelli (Table 4.3.5). Another important finding of the present 
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study was that incubation of two probiotic strains with a single pathogen strain resulted in greater                   
co-aggregation and more rapid and complete clearing of liquid in the culture tube (Table A.1 and 
Figure A.4, Appendix A). 
 This finding supports the idea that co-aggregation of probiotics with pathogens could 
potentially interfere with pathogen colonization of the GIT, survival (through various 
antimicrobial mechanisms) and subsequent manifestation of illness. One hypothesis is that        
co-aggregation of probiotics with other established commensal GIT microflora may aid in the 
attachment and colonization of probiotics to mucosal surfaces. The probiotic L. acidophilus 
ATCC 11975 tested in this study showed significant antibacterial activity against both Gram-
positive Cl. sordelli ATCC 9714 and Escherichia coli O157:H7 (Figure 4.3.5). This activity was 
possibly due to the antibacterial substances produced by this probiotic strain. It has been reported 
by several investigators that lactobacilli are able to produce antimicrobial substances when 
grown in specific media; a L. acidophilus strain produced lactacin (Barefoot et al., 1983), while a 
L. plantarum isolate produced plantaricin (Anderson et al., 1988). Corr et al. (2007) has 
demonstrated that the in vivo antimicrobial effects of L. salivarius UCC118 depended primarily 
on their capacity to produce the bacteriocin Abp118. 
Bacteria generally compete with each other by secreting antagonistic compounds, which 
may affect cell viability directly or indirectly by modifying the surrounding environment. In the 
present thesis research, strong probiotic antagonism against the tested pathogen strains was 
detected using the agar-spot method (Table 4.3.1). Interestingly, the probiotic strain did not 
exhibit the same antibacterial activity when cell free culture supernatant was tested using the 
agar-well diffusion method. Similar conflicting results have been reported by Harris et al. (1989), 
when seven LAB strains produced inhibitory zones against Listeria monocytogenes on solid 
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media, but only three of them produced inhibitory zones via the agar-well diffusion method. The 
inability to detect antibacterial activity in the probiotic supernatant in the present study may be 
due to the lower production of this substance; only in close proximity to the producing cells is a 
threshold concentration achieved necessary to exert an antimicrobial effect. Another possible 
explanation for the absence of antibacterial activity in the well-diffusion test is that cell-cell 
contact is necessary between probiotic and pathogen strains for the factor to be produced, 
something that would be absent when the culture supernatant was used.  Accordingly, physical 
contact between both producer organism (probiotic) and indicator (pathogens) in the same 
environment might actually be necessary for the induction and synthesis of the antimicrobial. 
Studies done by Toure et al. (2003) showed that the antibacterial activity of some bifidobacterial 
strains was recovered by concentrating the spent cultures by speed-vac. The fact that probiotic 
antagonism against the pathogens did not completely disappear when 0.2% sodium bicarbonate 
was added to the culture medium (Table 4.3.2; Figure 4.3.2) is strongly suggestive that other 
antibacterial factors, other than the effect of organic acids, were operative.  
Jacobsen et al. (1999) reported that the inhibitory activity of lactobacilli is variable even 
within the same species. In the present study, the mechanism(s) of pathogen inhibition was 
seemingly not due to the production of a proteinaceous compound like a bacteriocin, which 
exhibit antagonistic activity against taxonomically closely-related bacteria (Klaenhammer, 1993; 
Jack et al., 1995). Previous studies have demonstrated the production of broad-spectrum 
antibacterial substances, referred to as ’bacteriocin-like’ compounds, by different species of 
lactobacilli (Silva et al., 1987; Camard et al., 1997). Moreover, treatment of probiotic 
supernatant with either heat (100C for 10 min) or trypsin (1 mg/mL for 1 h) failed to eliminate 
the antagonistic activity of probiotic supernatant during growth inhibition assay (data not 
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shown). This suggests that the probiotic-dependent inhibitory activity observed in the current 
study was from the result of a heat stable non-proteinaceous substance. Niku-Paavola et al. 
(1999) identified various antimicrobial compounds in the culture filtrate of Lactobacillus 
plantarum, including benzoic acid, methylhydantoin and mevalonolactone, that were able to 
withstand heat treatment at 120°C for 15 min as well as trypsin (1mg/mL for 1 h at 37°C) 
treatment. However, it was also apparent that production of organic acid, which lowered the pH 
(4.5 ± 0.1) of the probiotic supernatant, was partially responsible for the observed antagonistic 
effect. Moreover, the fact that depletion of nutrients in probiotic supernatant could be a possible 
explanation for growth inhibition of pathogens (figure 4.3.5). The dominance of inhibitor-
producing lactobacilli in the gastrointestinal tract and the ability of these organisms to interact 
closely with enteric pathogens seemingly constitute an important host defense mechanism 
against infection. Further experiments identify the chemical nature of the antibacterial 
compound(s), and to establish the inhibition spectrum of the probiotic against a larger panel of 
pathogenic organisms are necessary. Current findings from this research suggest that L. 
acidophilus ATCC 11975 has the potential for interfering with disease-causing pathogens. Use 
of GIT model systems to evaluate this inhibitory potential, in vivo, would help establish this 
potential more clearly.  
5 General discussion and conclusions  
The greatest hurdles that probiotic bacteria must overcome during food processing, 
storage and in the upper GIT are acid and the presence of bile. A probiotic L. acidophilus strain 
exhibiting acid and bile tolerance has previously been isolated and evaluated. The present 
characterization studies indicated that Lactobacillus acidophilus ATCC 11975 was the most 
acid-tolerant strain (D-value 10.2 ± 0.80 min), able to survive 30 min at pH 2.0, and also bile-
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tolerant. Furthermore, the highest adhesion to Caco-2 cells was observed using L. acidophilus 
(4.5104 cfu/mL). L. acidophilus has the potential for interfering with disease-causing pathogens 
including Escherichia coli O157:H7 and Clostridium sordelli ATCC 9714. Co- and auto-
aggregation of L. acidophilus with enteric pathogens was also apparent in this study. Use of GIT 
model systems would help to evaluate the inhibitory potential of L. acidophilus more clearly. 
Knowledge of antimicrobial resistance patterns may also provide important information for 
consumption of naturally-resistant probiotics during antibiotic therapy, thereby protecting the 
intestinal mucosa from colonization of deleterious pathogenic strains. Screening for strains that 
can efficiently utilize certain prebiotics will provide competitive advantage for the probiotics in 
nutrient deficient large intestine. It is thought that the sole carbon source utilization profiles will 
provide useful information about the metabolic potential of the different probiotic 
microorganisms. Results showed that all probiotic strains grew to the highest culture optical 
densities on D-xylose. Further examination of substrate preferences of probiotics would be 
necessary for co-delivery of probiotics and prebiotics. In the present study, encapsulation of L. 
acidophilus strains with pea protein-alginate matrix was found to give 6 times more protection 
under acid stress. Thus future probiotic-prebiotic (synbiotic) combinational developments may 
be facilitated by screening the potential probiotic strain for desirable characteristics such as 
probiotic substrate preferences and antibiotic resistance profiling. As a physical delivery tool, 
delivery of probiotics, with or without prebiotics, within a capsule is suggested to improve the 
survival and subsequently enhance the growth potential of these beneficial bacteria in the GIT. 
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6 Recommendations 
 
Further identification and characterization of probiotic cell-wall properties is 
recommended to understand their role in adhesion to hydrocarbons, auto-aggregation, and 
relation to co-aggregation mechanisms. Selection of new probiotic combinations should be 
conducted for specific target pathogens or pathogen-associated microbiota aberrancies. 
Molecular techniques like multiplex RAPD-PCR, could be used to reveal the complete metabolic 
potential of each of the probiotic strain which opens the possibility to engineer new combinations 
of pre- and probiotics. 
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A.1 Screening for probiotic co-aggregation with other intestinal flora 
A.1.1 Bacterial adhesion to hydrocarbons 
 The percent adhesions of common enteric pathogens like Salmonella enteridis and 
Escherichia coli O157:H7, commensal microflora of GIT including Escherichia coli ATCC 
14763, Escherichia coli ATCC 4351, Enterococcus fecalis ATCC 19433, Enterococcus faecium 
ATCC 19434, and tested probiotics are shown in Figure A.1.  
 
 
 
 
 
Figure A.1 Hydrophobicity of probiotic and pathogen strains expressed as percentages. The data are 
expressed as the mean ± one standard deviation (n=3) 
 
 
The effect of MgCl2, CaCl2, EDTA and oxgall bile on cell surface hydrophobicity of 
probiotics is shown in Figure A.2. Cell surface hydrophobicity of all tested probiotics was found 
to be reduced as the concentration of MgCl2 was increased from 0.5-5 mM, and EDTA 
concentration from 100-500 µM. Addition of CaCl2 (0.5-10 mM) in MRS media was found to 
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increase the cell surface hydrophobicity of all tested probiotics. Interestingly, the percent 
hydrophobicity decreased with the addition of Oxgall bile. Increase in bile concentration from 
0.1-0.5% (w/v) caused a further decrease in hydrophobicity. 
 
 
Figure A.2 Effect of different concentrations of A) MgCl2, B) CaCl2, C) EDTA and D) 0.3% Oxgall bile 
(w/v) on cell surface hydrophobicity of L. acidophilus (●), B. catenulatum (○), B. adolescentis (▼) and B. 
infantis (Δ). The data are expressed as the mean ± one standard deviation (n=3) 
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A.1.2 Bacterial auto-aggregation analysis  
The auto-aggregation properties of probiotic and pathogen strains were tested over a 
period of 24 h by visual observation of aggregates formed as well as by absorbance 
measurements. The results obtained by absorbance measurements are shown in Figure A.3.  
 
Figure A.3 Autoaggregation of probiotic and pathogen strains expressed as percentages. The data are 
expressed as the mean ± one standard deviation (n=3) 
 
 
 In general, the probiotic strains presented higher auto-aggregation abilities than the 
pathogens when examined at 37C. This temperature was chosen because 37C is the normal 
body temperature. The pathogen with the greatest auto-aggregation potential was E. coli O157, 
whereas the probiotic strain with the greatest auto-aggregation potential was B. catenulatum. 
BATH values (Figure A.1) were related to auto-aggregation properties (Figure A.3) because 
most of the strains with higher adhesion to hydrocarbons also showed high auto-aggregation 
abilities. Among the tested probiotic strains, L. acidophilus and B. catenulatum showed highest 
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percent adherence to hydrocarbon (% BATH) and also highest auto-aggregation abilities. B. 
adolescentis and B. infantis showed a lower % BATH as well as lower autoaggregation. 
A.1.3 Visual co-aggregation analysis 
Visual co-aggregation of two probiotic strains in combination with other intestinal flora, 
including E. coli 4351, E. coli 14763, Alcaligens fecalis, E. faecium and E. fecalis and pathogen 
strains is shown in Table A.1. All tested probiotics showed co-aggregation with some of the 
commensal and pathogenic bacteria in the test panel. It was interesting to note that incubation of 
two probiotic strains with a single pathogen strain resulted in greater co-aggregation and more 
rapid and complete clearing of liquid in the culture tube. Figure A.4 shows photomicrographs of 
the precipitated floccules.  
  
Table A.1 Coaggregation of different combinations of probiotic bacteria with enteric pathogens and 
commensal bacteria 
 
Probiotic combinations 
Bacteria LA+BA LA+BC LA+BI BA+BC BA+BI BC+BI 
E. coli 4351 +++ ++++ +++ + ++++ ++++ 
E. coli 14763 +++ +++ ++ ++ ++++ ++++ 
E. coli O157 ++ +++ ++ ++++ ++ ++++ 
S. enteritidis ++++ ++++ ++ ++++ ++ ++++ 
Al. fecalis ++++ ++++ +++ ++++ ++++ ++++ 
E. faecium ++++ ++++ +++ ++++ ++++ ++++ 
E. fecalis +++ ++++ +++ ++++ ++++ ++++ 
LA, L. acidophilus; BA, B. adolescentis; BC, B. catenulatum; BI, B. infantis 
(+) for small uniform aggregates in the suspension, (++) for aggregates that are easily seen but 
do not settle, (+++) for large aggregates which settle and leave some turbidity in the supernatant 
fluid, and (++++) for large aggregates which settle and leave clear supernatant fluid. 
 
The formation of aggregates was dependant on the strains tested (probiotic and pathogen 
strains) and also the concentration and time of co-incubation. Formation of aggregates was found 
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to be dependant on the concentration of pathogen and probiotic strains. It was noted that when 
the concentration of pathogen was lower than the probiotic, complete clearing of liquid in the 
culture tube containing combination of probiotics and pathogen was observed. This finding 
supports the idea that given the low infective dose of certain pathogens, co-aggregation with 
commensal or probiotic microbiota could potentially help wash them from the GIT, thus 
preventing their colonization and manifestation of illness. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.4 Photomicrographic images of co-aggregates of L. acidophilus, B. adolescentis and S. 
enteritidis in combination; A) Unstained bacteria before incubation, B) Unstained co-aggregates after 
incubation at 37ºC for 24 h, and C) Fluorescently-stained (BacLightTM Live/Dead stain) co-aggregates  
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